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Abstract 
Mastitis is a costly disease which hampers the dairy industry. Inflammation of the mammary gland 
is commonly caused by bacterial infection, mainly Escherichia coli, Streptococcus uberis and Staphy-
lococcus aureus. As more bacteria become multi-drug resistant, one potential approach to reduce 
the disease incidence rate is to breed selectively for the most appropriate and potentially protec-
tive innate immune response. The genetic contribution to effective disease resistance is, however, 
difficult to identify due to the complex interactions that occur. In the present study two published 
datasets were searched for common differentially expressed genes (DEGs) with similar changes in 
expression in mammary tissue following intra-mammary challenge with either E. coli or S. uberis. 
Additionally, the results of seven published genome-wide association studies (GWAS) on different 
dairy cow populations were used to compile a list of SNPs associated with somatic cell count. All 
genes located within 2 Mbp of significant SNPs were retrieved from the Ensembl database, based 
on the UMD3.1 assembly. A final list of 48 candidate genes with a role in the innate immune re-
sponse identified from both the DEG and GWAS studies was further analyzed using Ingenuity 
Pathway Analysis. The main signalling pathways highlighted in the response of the bovine mam-
mary gland to both bacterial infections were 1) granulocyte adhesion and diapedesis, 2) ephrin 
receptor signalling, 3) RhoA signalling and 4) LPS/IL1 mediated inhibition of RXR function. These 
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pathways comprised a network regulating the activity of leukocytes, especially neutrophils, dur-
ing mammary gland inflammation. The timely and properly controlled movement of leukocytes to 
infection loci seems particularly important in achieving a good balance between pathogen elimi-
nation and excessive tissue damage. These results suggest that polymorphisms in key genes in 
these pathways such as SELP, SELL, BCAR1, ACTR3, CXCL2, CXCL6, CXCL8 and FABP may influence 
the ability of dairy cows to resist mastitis. 
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1. Introduction 
Mastitis in dairy cows, characterized by a high cell count in the milk, is one of the most economically serious 
diseases of livestock worldwide. In the UK there are around 40 cases of clinical mastitis per 100 cows. It is es-
timated that 70% of these are mild (being treated by the farmer), 29% are severe (requiring a visit from the vete-
rinarian) and 1% are fatal [1]. Continuous genetic selection for milk production in modern high yielding dairy 
cows has been associated with an increased incidence of mastitis [2] [3]. Poor health reduces longevity and 
causes serious economic losses [4]. The bacteriological aetiology of mastitis has changed over recent years from 
primarily contagious forms (such as Staphylococcus (St.) aureus) to environmental pathogens (such as Escherichia 
(E.) coli and Streptococcus (S.) uberis) [5]. Conventional treatment requires antibiotic therapy but traditional 
mastitis control strategies are not fully efficient against environmental pathogens [6]. This raises major concerns 
over antibiotic residues in food products as well as an ever increasing rate of antimicrobial resistance [7]. Alter-
native options are urgently needed for efficiency, health and sustainability of the dairy industry. This need will 
be even more urgent in future as antibiotic usage in farm livestock becomes increasingly restricted. 
Many studies have indicated that the host defence status is a key factor determining the severity of mastitis [8] 
[9]. The innate response offers the first line of defence in the bovine mammary gland, potentially helping the 
host to eliminate invading pathogens at an early stage, thus minimizing adverse effects [10]. This rapid early re-
sponse is of key importance as adaptive immune responses seem to fail to induce long-lasting protection [11]. A 
more sustainable approach to decrease the incidence of disease and improve health in dairy cattle is thus by ge-
netic selection, utilizing gene polymorphisms for enhanced innate immunity [12]. Such genetic improvement 
could potentially result in cumulative, permanent and cost-effective change. The candidate genes for genetic se-
lection are, however, difficult to identify due to the complex interactions that must occur for effective disease 
resistance.  
A recent UK survey showed that S. uberis and E. coli were the predominant pathogens isolated from clinical 
mastitis cases and S. uberis from subclinical cases [13]. Different bacterial species lead to different host responses 
[14]. Differentially expressed gene (DEGs) profile studies have provided much useful information for under-
standing dairy cow mastitis. These profiles have been derived from cattle challenged in vivo with St. aureus [15], 
E. coli [16] [17] and S. uberis [18] [19]. Additional in vitro studies have investigated the responses of bovine 
monocyte-derived macrophages to St. aureus [20] and mammary epithelial cells to both St. aureus and E. coli 
[21] [22]. These studies have revealed some important differences between Gram-negative and Gram-positive 
bacterial species in terms of both the time course and magnitude of the response as well as which genes are dif-
ferentially expressed. Gram-negative E. coli infections are generally of short duration with a high bacterial count 
and induce a rapid and strong rise in the pro-inflammatory cytokines TNFα, IL1β and IL6 in mammary tissue 
via TLR4-dependent lipopolysaccharide (LPS) induced signalling. This results in a fast influx of neutrophils to 
inhibit bacterial growth [11]. On the other hand, Gram-positive bacteria such as S. uberis cause a slower and less 
dramatic response [23] while St. aureus is better able to evade the host immune response leading to a more per-
sistent infection. In these instances, TLR signalling increases IL6 expression but does not up-regulate TNFα and 
IL1β [11]. Despite these species-specific responses, similarities still exist across bacterial species, such as the 
up-regulation of genes related to the innate immune response and down-regulation of genes related to fat me-
tabolism [16] [18]. Indeed, several innate immune response pathways show evolutionary conservation independent 
of the infecting pathogens [24]. This increases the feasibility of finding common defence mechanisms against 
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mastitic infections caused by different bacterial species, which is necessary to develop a more efficient breeding 
strategy for dairy cows.  
Allele-phenotype association studies, especially genome-wide association studies (GWAS), offer another source 
of valuable information for understanding genetic mechanisms underlying different dairy cow phenotypes. This 
provides a powerful tool to map QTL of important dairy traits onto the genome. Several GWAS using bovine 
SNP chips have investigated associations between mastitis incidence and somatic cell count (SCC) in different 
dairy cow populations [25]-[33]. SCC is generally more informative than clinical case recording for this purpose 
as it is recorded regularly and consistently from all cows in the herd in a more extensive and reliable manner. In 
general, mastitis incidence increases with increasing SCC [34] and the genetic correlation between SCC and 
clinical or subclinical mastitis is positive [35] [36]. There is however a U shaped distribution as cows with a 
very low SCC may have fewer immune cells present in their udders, making them more susceptible to infection 
[11]. Results from GWAS studies thus present us with a fragmented but key insight into which areas of the ge-
nome may be associated with improved resistance to mastitis. 
We hypothesize that important common innate immune defence mechanisms exist in dairy cows to different 
sources of intra-mammary infection and that variance in the key genes associated with these mechanisms can 
lead to differences in disease resistance. Identifying these common and bacterial-species independent pathways 
is an essential step in developing an appropriate future breeding strategy. Supporting that this approach is feasi-
ble comes from a comparison of the responses of mammary epithelial cells derived from two groups of German 
Holstein heifers which are selected for high or low susceptibility to mastitis using marker assisted selection for a 
haplotype on BTA18 which is associated with SCC [22] [37]. Gene expression profiles found that the more re-
sistant animals showed a quicker and stronger response to both E. coli and St. aureus with greater expression of 
the cytokines IL1β, IL6, IL8 and TNFα, and the chemokines CXCL2 and CXCL3 and NFKB1A. These studies 
suggested that RELB, a transcription regulator in the NF-κB family, was the gene most likely to be responsible 
for the quantitative trait locus (QTL).  
In the present paper, we have undertaken a systematic integrated analysis on expression and association pro-
filing to search for such potential common defence mechanisms (innate immunity) and different genetic mecha-
nisms (gene polymorphisms) existing in dairy cows which alter their responses to invading pathogens within the 
mammary gland.  
2. Materials and Methods 
2.1. Data and Differential Expression Analysis 
Two gene expression profiles from the Gene Expression Omnibus (GEO) database (accession numbers GSE15025 
and GSE15344) were used to search for common DEGs whose expression in mammary tissue samples was al-
tered following intra-mammary challenge with either E. coli (using Affymetrix Bovine Genome Array, platform 
GPL2112) [17] or S. uberis (using UIUC Bostaurus 13.2 K 70-mer oligoarray (condensed), made by W.M. Keck 
Center, University of Illinois Urbana-Champaign, platform GPL8776) [18]. The results of these two studies were 
chosen for analysis because: 1) E. coli and S. uberis are representative gram negative and gram positive bacteria 
respectively; 2) they are both common environmental pathogens causing mastitis [5] [13]; 3) the expression pro-
files were generated at similar times after the start of infection (20 - 24 h), which is the stage associated with in-
nate immunity. The microarray data were analysed using a moderated student t-test with the Benjamini-Hochberg 
(BH) adjustment for false discovery rate (FDR) control using GeneSpring GX12.5 software (Agilent Technolo-
gies, Santa Clara, CA), according to gene accession number and experimental group as described in the GEO 
database and related articles [17] [18]. Fold changes were calculated as: Infected/Control where Infected ≥ Con-
trol (up-regulation) and -Control/Infected where Infected < Control (down-regulation). P values were calculated 
based on a moderated t-test (tow sided) built in GeneSpring V12.5. The moderated variance was calculated as 
following where Sm1-m2 is the variance across the conditions, m1 and m2 are the mean expression values for gene 
g within groups, df(m1-m2) = n1 + n2 – 2, Sglobal and dglobal are the prior variance and degrees of freedom, respec-
tively: 
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The moderated t value was calculated as: 
1 2
gmod
mod
m mt
S
−
=  
The data obtained at 20 h and 24 h respectively following intra-mammary bacterial inoculation were used for 
the analysis. At this time point it was considered that the treatment would have triggered an innate immune re-
sponse in defence against the invading pathogens. However, as relatively few neutrophils had invaded the 
mammary gland by 20 h following S. uberis infection [18], DEG data may reflect mainly differences in gene 
expression of mammary epithelial cells. All the DEGs with similar expression patterns in both data sets and fold 
changes in response to E. coli infection > 1.5 or S. uberis infection > 2 were selected (Table S1). These different 
cut-off values were chosen due to the different microarray platforms used in the two previous experiments (E. 
coli: Affymetrix one colour/channel array; S. uberis: two colour/channel customised array) [17] [18]. Based on 
the nature of the microarray platforms, the data for the Affymetrix array were normalised using the Robust 
Multi-array Average (RMA) method whereas those for the two colour array were normalised with Lowess re-
gression. Use of the different cut-off values in our study thus provided an appropriate number of genes for fur-
ther analysis from each of the original data sets. 
2.2. Candidate Genes Based on Genome-Wide Association Study (GWAS) 
Significant SNPs identified by GWAS in seven different dairy cow populations were used to select candidate 
genes associated with somatic cell count (SCC) (Table 1). Genes located within 2 Mbp upstream and down-
stream of significant SNPs were retrieved from the Ensembl database with the position based on the UMD3.1 
assembly at http://www.ensembl.org.The SNPs located on the same chromosome within 2 Mbp were consid-
ered as a block when looking for candidate genes. All the SNPs and adjacent genes included are listed in Ta-
ble S2. 
2.3. Data Integration of Gene Expression and GWAS 
The two datasets from the differential expression and GWAS analyses were integrated. The 48 common genes 
which appeared on both lists represented genes with a putative role in responding to infection with organisms 
causing mastitis (Figure 1 and Table 2). 
2.4. Selection of Candidate Genes Involved in the Innate Immune Response 
Annotation was initially provided by GeneSpring Technology files updated on May 2014 and gene function 
clustering via Ingenuity Pathway Analysis (IPA, Ingenuity Systems, Redwood City, CA.  
http://www.ingenuity.com). The 48 shortlisted candidate genes were further annotated using a number of data-
bases available online, including the NetAffx™ analysis center toolbar on the Affymetrix website  
(http://www.affymetrix.com) and GeneCard (http://www.genecards.org). The genes were also compared with 
the innate immune genes database InnateDB (http://www.innatedb.com). After screening, only genes contribut-
ing to “inflammatory response” or “innate immunity response” were considered for further analysis. 
 
Table 1. Summary of studies using GWAS to identify SNPs associated with somatic cell count in different dairy cow popu-
lations. 
Population SNP chip No. significant SNPs Reference 
Canadian Holsteins 1536 SNP Marker Chip 11 Kolbehdari et al. [26] 
U.S. Holsteins BovineSNP50 Bead Chip 20 Cole et al. [28] 
Norwegian Red cattle Affymetrix 25K MIP Array 29 Sodeland et al. [29] 
Netherlands Holsteins BovineSNP50 Bead Chip 1 Wijga et al. [30] 
Irish Holstein-Friesian BovineSNP50 Bead Chip 5 Meredith et al. [31] 
Nordic Holsteins BovineSNP50 Bead Chip 21 Sahana et al. [32] 
German Holstein Unknown 10 Abdel-Shafy et al. [33] 
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Table 2. List of 48 candidate genes with significant changes in expression in mammary tissue in response to both E. coli and 
S. uberis and which were also located close to significant SNPs in gene association studies with SCC. See Materials and 
Methods section for details on calculations of significance. #Bold denotes the genes located within 1Mbp around significant 
SNPs associated with SCC. The remainder were within 2 Mbp. 
Gene symbol# 
E. coli S. uberis 
Significant SNPs 
P Fold change P Fold change 
FASN 2.40E−06 −4.39 8.83E−03 −2.51 rs41257403 
FABP4 3.18E−05 −2.89 2.85E−05 −2.93 rs41629827 
RHPN2 3.52E−06 −2.71 5.48E−04 −2.73 rs29020544 
ACSS2 4.86E−06 −2.48 7.37E−03 −2.27 rs41576572 
NOV 8.64E−05 −2.10 4.87E−03 −2.36 rs41629827 
ROGDI 4.29E−05 −2.08 6.60E−03 −2.32 Hapmap25382−BTC−000577 
CBFA2T3 7.95E−06 −2.06 2.93E−03 −2.23 rs110754697 
SORBS1 2.09E−04 −2.03 9.37E−03 −2.46 rs41650611 
ALDH18A1 7.01E−07 −1.88 2.36E−03 −2.34 rs41650611 
BDH2 1.03E−04 −1.82 5.96E−03 −2.40 rs41664497 
FAM110A 9.80E−04 −1.62 1.08E−03 −2.30 rs41601522 
HSF1 1.75E−05 −1.61 7.46E−03 −2.15 rs109421300 
EMX2 1.63E−03 −1.55 5.62E−03 −2.37 rs41606777 
GNAS 2.59E−04 −1.52 9.46E−03 −2.27 rs41694067 
CST6 5.04E−04 −1.52 6.63E−03 −2.21 rs29027496 
SRL 2.89E−03 1.51 1.05E−03 2.21 Hapmap25382−BTC−000577 
SLC25A16 7.48E−03 1.52 1.50E−04 2.31 rs41655339 
MRPL12 6.69E−03 1.53 8.58E−03 2.27 rs41636878 
EIF4E 2.24E−05 1.54 2.11E−03 2.35 rs110927426 
MAPRE1 1.44E−04 1.58 3.23E−04 2.44 rs29022774 
GSPT1 7.42E−04 1.59 5.60E−03 2.42 BFGL−NGS−119848 
CRNKL1 1.49E−04 1.62 4.51E−03 2.26 rs41628293 
DDX27 1.15E−04 1.63 4.46E−04 2.33 rs109934030 
BCAR1 2.77E−03 1.66 3.06E−05 2.54 rs29014958 
TRIP10 1.78E−04 1.72 1.61E−04 2.71 rs110066189 
RBM14 4.16E−05 1.76 6.57E−04 2.35 rs29027496 
TARS 3.15E−04 1.78 5.80E−04 2.39 rs41578305 
ZNFX1 9.71E−05 1.81 9.50E−04 2.53 rs109934030 
SULF2 1.81E−05 1.89 3.73E−03 2.33 rs109934030 
B4GALT5 1.21E−03 1.93 7.58E−05 2.53 rs109934030 
CDC42SE2 3.07E−07 1.99 6.06E−04 2.37 rs41657989 
RSL1D1 1.75E−06 2.00 1.20E−04 2.65 BFGL−NGS−119848 
SLC6A9 1.11E−05 2.16 6.49E−03 2.35 rs41628293 
TPM4 7.88E−06 2.22 4.11E−03 2.39 rs110213141 
SELP 2.57E−03 2.24 1.03E−04 4.69 rs41579632 
SPRY1 1.59E−04 2.27 8.90E−04 2.32 rs41616806 
ANTXR2 2.80E−06 2.41 3.73E−03 2.35 rs41653149 
ACTR3 1.26E−07 2.49 1.89E−05 2.69 BTA−47902 
ZFP36L2 2.08E−07 2.75 3.29E−04 2.91 rs43673004 
EHBP1L1 2.58E−07 2.76 8.50E−04 2.92 rs29027496 
PIK3AP1 3.10E−06 3.03 4.64E−05 2.44 rs41650611 
CTSZ 1.31E−07 3.10 1.31E−03 2.25 rs41694067 
PGS1 3.22E−08 3.51 5.73E−03 2.42 rs41636878 
SELL 3.70E−09 9.41 4.88E−05 2.63 rs41579632 
CXCL6 3.54E−10 36.81 6.16E−04 4.01 rs41617692 
EMR1 2.94E−11 63.30 8.90E−05 6.02 rs110066189 
CXCL8 1.02E−09 82.99 1.33E−04 5.64 rs41617692 
CXCL2 2.02E−09 94.97 4.47E−04 3.08 rs41617692 
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2.5. Gene Function and Pathway Analysis by IPA 
The two separate and one combined gene lists were each analysed using IPA to mine the relationships via 
grouping DEG into known functions, pathways, and networks. Information in IPA is based primarily on human 
and rodent studies but is still relevant to the cow. The fold change in response to E. coli infection and the associ-
ated P-value data were used for the IPA analysis. All the DEGs were included without fold-change cut-off. Most 
genes were mapped to their corresponding gene object in the IPA Knowledge Base considering both the direct 
and indirect relationship. Several analyses were run including Functional Analysis, Network Generation, Ca-
nonical Pathway Analysis and Upstream Regulators Effects Analysis.Fisher’s exact test with BH-FDR control at 
P < 0.05 was used to determine the biological functions and canonical pathways significantly altered by the 
treatment. These analyses integrate data from a variety of experimental platforms and provide insight into the 
most likely molecular and chemical interactions between the DEG which have been identified. 
3. Results 
3.1. Differential Expression of Genes Following Intra-Mammary Infection with 
E. coli or S. uberis 
The comparison of the list of genes identified by expression microarrays at 20 - 24 h after intra-mammary infec-
tion with either E. coli or S. uberis yielded 505 common genes with a significant fold change (>1.5) in a similar 
direction and p-values < 0.001. Of these, 348 genes were up-regulated and 157 genes were down-regulated 
(Table S1). When these genes were imported into IPA, 504 genes were mapped based on annotation to human 
or mouse within the IPA Knowledge. The top ten most significant signalling pathways are listed in Table S2. 
These included IL-10 and IL-6, glucocorticoid- and ephrin-receptor signalling and activation of LXR/RXR and 
PPARα/RXRα. The primary function analysis is given in Table S3. As expected, the most significant functions 
were associated with inflammatory responses, connective tissue disorders and immune cell trafficking and cell 
death, survival, proliferation and movement.  
3.2. Candidate Genes from Mastitis Association Studies on Different Dairy Cow Populations 
Based on the seven different GWAS studies listed in Table 1 that looked for associations with SCC, a total of 94 
significant SNPs were identified (Table S4). One SNP (BTB-00495251) could not be found in the NCBI SNP 
database, so 93 were used in this study. These SNPs were distributed on most chromosomes but with higher 
density attributed to BTA6 (n = 27), BTA13 (n = 11), BTA20 (n = 9), BTA2 (n = 7), BTA14 (n = 7) and BTA7 
(n = 5). Four SNPs located in BTA6 were selected in 2 different populations (rs41588957, rs110707460, 
rs108988814, rs42766480).The nearest genes to these were TMPRSS11F, DCK, GC and NPFFR2 respectively.  
A total of 1635 protein-coding genes were located within 2 Mbp of the 93 significant SNPs (Table S4). These 
were input for IPA analysis and 1568 of them were mapped and used for further analysis. Function analysis in-
dicated that 209 genes were related with infectious disease and 73 were involved in inflammatory responses in-
cluding the genes NFKB1 and CXCR2. Primary function analysis of Molecular and Cellular Functions showed 
that 76 genes were involved in Cell-to-Cell Signalling and Interaction and 76 genes were related to Cellular 
Movement. At the Physiological System Development and Function level, 181 genes were involved in Haema-
tological System Development and Function and 53 in Immune Cell Trafficking (Table S5).The top 10 canoni-
cal pathways included both agranulocyte (mononuclear leukocytes) and granulocyte adhesion and diapedesis 
(Table S6). 
3.3. Common Genes from Both the Gene Expression and SCC Association Studies 
When the gene lists from the two sources were compared (Figure 1), 48 common genes emerged. Those genes 
located around the significant SNPs had similar changes in expression in response to intra-mammary infection 
caused by either E. coli or S. uberis. Of these genes, 30 were located within 1 Mbp around the significant SNPs 
(Table 2). These included 5 genes of particular interest, FABP4, SELE, SELP, CXCL2 and CXCL6, since some 
other genes with similar function from the same families are located in close chromosome areas (Table 3). 
Seven genes (EIF4E, HSF1, PIK3AP1, PRMT1, BCAR1, CXCL8, CXCL2) were annotated as having a role in 
the innate immune response by the innateDB database (http://www.innatedb.com). IPA function analysis indi- 
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cated that 13 genes (CST6, CXCL2, CXCL6, CXCL8, EMR1, FABP4, HSF1, SELL, SELP, CTSZ, SORBS, GNAS, 
ZFP36L2) were clustered into inflammatory responses. Of these 18 genes with a role in innate immunity and in-
flammation, 11 were mapped in Network 1 and/or the signalling pathways Granulocyte Adhesion and Diapede-
sis and Ephrin Receptor Signalling. This included seven genes located within 1 Mbp around the significant SNPs 
(Table 3). 
When this final list of 48 genes was analysed by IPA the results remained similar to those initially detected 
from the 504 genes with common responses to E. coli and S. uberis (Table 4). Inflammatory responses were  
 
 
Figure 1. Venn diagram showing common genes associated with responses to mastitis in dairy cows. Candidate genes were 
identified using three different experimental approaches. Differential gene expression from mammary tissue infected with 
(a) E. coli (blue) [17] or (b) S. uberis (yellow) [18]. (c) A combined set of candidate genes set from seven different associa-
tion studies with SCC (green) (see Table 1 for references). A common set of 48 genes existed among the three different gene 
sets. 
 
Table 4. IPA function analysis on the 48 candidate genes associated with mastitis in dairy cows in the studies of both gene 
expression and GWAS*. 
Name Molecules 
Diseases and Disorders  
Inflammatory Response 13 
Dermatological Diseases and Conditions 9 
Organismal Injury and Abnormalities 23 
Gastrointestinal Disease 28 
Hepatic System Disease 14 
Molecular and Cellular Functions  
Cellular Movement 17 
Cell-To-Cell Signalling and Interaction 13 
Cell Cycle 9 
Cellular Development 24 
Cell Death and Survival 18 
Physiological System Development and Function  
Hematological System Development and Function 16 
Immune Cell Trafficking 9 
Tissue Development 20 
Tissue Morphology 16 
Cell-mediated Immune Response 3 
*All functions were identified using a Fisher’s exact test with BH-FDR control at P < 0.05. 
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identified as the most significant in the Diseases and Disorders category, and Cellular movement, Cell-to-cell 
signalling and interaction, Cell death and survival and Cellular growth and proliferation were all important un-
der the Molecular and Cellular Functions category. Haematological system development and function and Im-
mune cell trafficking were the most significant under physiological system development and function. Table 5 
shows the top five canonical pathways. These included Granulocyte adhesion and diapedesis and Ephrin recep-
tor signalling. 
The physiological responses triggered by Granulocyte adhesion and diapedesis are illustrated in Figure 2. 
This shows that the neutrophil recruitment cascade is initiated by exposure of macrophages and epithelial cells  
 
Table 5. Top canonical pathways from IPA on the 48 candidate genes associated with mastitis in dairy cows which were 
common in the studies of both gene expression and GWAS*. 
Top canonical pathways+ Changed genes found in both datasets# 
Granulocyte Adhesion and Diapedesis CXCL8, SELL, SELP, CXCL2, CXCL6 
Agranulocyte Adhesion and Diapedesis CXCL8, SELL, SELP, CXCL2, CXCL6 
Role of IL-17A in Psoriasis CXCL8, CXCL6 
Ephrin Receptor Signalling ACTR3, BCAR1, GNAS, SORBS1 
Stearate Biosynthesis I (Animals) BDH2, FASN 
+All pathways were identified using a Fisher’s exact test with BH-FDR control at P < 0.05. 
#Bold denotes up-regulation and underscore denotes down-regulation of the gene. 
 
 
Figure 2. Summary diagram showing neutrophil adhesion and diapedesissignalling following intra-mammary infection. The 
505 common DEGs following infection with either S. uberis or E. coli were mapped in IPA. Red denotes gene up-regulation 
and green denotes gene down-regulation. Underscore denotes genes located around significant SNPs. ((1), (2)) initiation of 
the neutrophil recruitment cascade by exposure of macrophages and epithelial cells to LPS or LTA inducing cytokine and 
complement C5a up-regulation together with histamine release from mast cells. (3) Tethering of neutrophils to the endothe-
lium followed by rolling and activation. (4) Integrins binding to their ligands make firm adhesion between neutrophils and 
endothelial cells. (5) Diapedesis: neutrophils crawl to an endothelial junction then transmigrate using multiple adhesion mo-
lecules. (6) Emigrated neutrophils are recruited by moving up a new chemotactic gradient then migrating into the lumen of 
the mammary gland through the epithelium. (7) Activated neutrophils then play a key role in pathogen elimination. 
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to LPS (from Gram-negative bacteria) or lipoteichoic acid (LTA, from Gram-positive bacteria) that both induce 
expression of TNFα and IL1B. Complement C5a is also increased during infection and induces histamine re-
lease from mast cells [38]. TNFα, IL1β, C5a and histamine interact with their respective receptors on vascular 
endothelial cells and trigger their response [39] [40]. There is increased expression of the adhesion molecule 
P-selectin (SELP) following both E. Coli and S. uberis infection and during E. coli infection E-selectin (SELE) 
is also increased. Selectins binds their glycosylated ligands, including P-selectin glycoprotein ligand 1 (PSGL1) 
on the neutrophils, leading to tethering and subsequent rolling. L-selectin expression by circulating neutrophils 
may facilitate their secondary tethering to an already rolling neutrophil. The rolling of neutrophils facilitates 
their contact with the chemokine-decorated endothelium to induce activation of integrins (LFA1, MAC1). Acti-
vated integrins present higher affinity for their ligands, including immunoglobulin-like cell adhesion molecules 
(CAMs) [41]. Integrins binding to their ligands make firm adhesion between neutrophils and endothelial cells. 
Note that the crucial integrin LFA1 increases significantly in E. coli infection but not in S. uberis [16] [17]. 
Neutrophils then crawl to an endothelial junction by co-action of blood shear and adhesion before diapedesis 
(transmigration) using multiple adhesion molecules [42]. Emigrated neutrophils move up a new chemotactic 
gradient then migrate into the lumen of the mammary gland through the epithelium where they play a key role in 
pathogen elimination [43]. 
The physiological responses triggered by Ephrin receptor signalling are illustrated in Figure 3. Cytokines 
such as TNFα are released into the tissue where signalling via ephrin receptors causes changes in vascular en-
dothelial cells promoting leukocytes to become adherent. This leads to cytoskeleton reorganization and neutro-
phil migration mainly mediated by the Rho family of small GTPases (RhoA, Cdc42, Rac) and CAS [44] [45]. 
Such a process would be essential in the recruitment of leucocytes into infected mammary tissue. 
 
 
Figure 3. Summary diagram showing ephrin receptor signalling in vascular endothelial cells and neutrophils after their ad-
hesion. The genes shown were among the common 505 DEGs following intra-mammary infection with either S. uberis or E. 
coli. Red denotes gene up-regulation and green denotes gene down-regulation. Underscore denotes genes located around 
significant SNPs. Ephrin receptor signalling changes in vascular endothelial cells in response to cytokines (e.g. TNFα) being 
released into the tissue and leukocytes becoming adherent to the endothelial cells. This leads to cytoskeleton reorganization 
and neutrophil migration mainly mediated by Rho family of small GTPases (RhoA, Cdc42, Rac) and CAS). Leukocyte mi-
gration into the mammary gland is a crucial step in the immune response. 
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Upstream Regulator Effect Analysis of the 48 candidate genes in IPA presented the cytokine TNFα as the one 
important regulator which significantly influences chemotaxis of neutrophils and their predicted activation though 
the transcription factor EGR1. This agrees with the finding that these two genes were both significantly up-regu- 
lated after infection by E. coli or S. uberis (Table S1). EGR1 in turn causes up-regulation of CXCL2, CXCL6 
and CXCL8. 
The 48 common genes which were identified from both the gene expression and GWAS studies were all con-
tained in four main networks as revealed by IPA analysis (Table 6). The two most significant networks with 
scores > 37 were involved in: 1) Cancer, Organismal Survival, Cellular Movement and 2) Haematological Sys-
tem Development and Function, Humoral Immune Response, Lymphoid Tissue Structure and Development. 
Most of the genes annotated as innate immunity by GO terms, for example CXCL2, CXCL6, CXCL8, SELL, 
SELP and FABP4, were included in Network 1(Figure S1). 
Several of the analytical approaches indicated an important role for lipid signalling, specifically long chain 
fatty acids (LCFA). FASN and FABP4 were the two most highly down-regulated genes from the expression stu-
dies (Table 2). Both these genes are involved in mammary gland lipid metabolism and are associated with SNPs 
identified from the GWAS studies (Table 3). They also both appear in Network 1 (Table 6). The IPA analysis 
of the 504 genes common to the expression studies listed LXR/RXR activation and PPARα/RXRα activation in 
the top 10 signalling pathways (Table S2). These three nuclear receptors are all known to play a role in the reg-
ulation of inflammation and in fasting mediated changes in metabolism involved in switching from utilization of 
glucose to LCFAs as the main source of energy [46]. 
4. Discussion 
4.1. Experimental Approach Used 
In the present study we have used the combined approach of examining previous results from both differential 
gene expression analysis and GWAS studies to identify the key pathways and candidate genes which potentially 
confer a different degree of genetic resistance to mastitis caused by bacterial pathogens in dairy cows. While this 
approach may be somewhat controversial, we believe that it has two main benefits. Firstly it helps to select those 
genes which contribute to a generalised response against all species/strains of bacteria which can cause mastitis 
from among the many hundreds of genes which are up- or down-regulated following a bacterial challenge. Sec-
ondly it aids in the identification of the gene(s) most likely to be causative for a QTL when examining the rele-
vant chromosomal region. Our analysis has suggested that there are sequence variations in genes which control 
 
Table 6. Top 4 IPA networks involving the 48 genes selected in the studies of both gene expression and GWAS. 
ID Molecules in network# Score Top diseases and functions 
1 
Alpha Actinin, Alpha catenin, ANTXR2, BCAR1, CBFA2T3, Cg, Collagen type 
IV, Collagen(s), CXCL2, CXCL6, CXCL8, EIF4E, EMX2, ERK1/2, FABP4, 
FASN, Growth hormone, HSF1, Hsp27, CXCL8r, LDL, Mek, N-cor, NOV, Nr1h, 
Pdgf (complex), PDGF BB, Rock, SELL, SELP, SORBS1, Sos, SPRY1, SULF2, 
Tnf (family) 
40 Cancer, Organismal Survival, Cellular Movement 
2 
ACKR3, ACSS2, AIMP1, ALDH18A1, BDH2, BRD4, CRNKL1, CSF2RB, 
DDX27, DNAJA3, EHBP1L1, FAM110A, GRB2, GSN, GSPT1, IRF6, KRT14, 
KRT17, LAT2, MAPRE1, MAVS, MRPL12, PGS1, PIK3CD, PTPRE, PTPRJ, 
RBM14, RHPN2, RSL1D1, S100A6, SH3BP2, TARS, TPM1, TPM4, UBC 
37 
Hematological System Devel-
opment and Function, Humoral 
Immune Response, Lymphoid 
Tissue Structure and Develop-
ment 
3 
ACTR3, ADCY, Akt, AMPK, Ap1, B4GALT5, BCR (complex), CD3, 
CDC42SE2, Creb, CTSZ, ERK, estrogen receptor, GNAS, Histone h3, Ige, IgG, 
IL1, IL12 (complex), Immunoglobulin, Insulin, Interferon alpha, Mapk, Nfat 
(family), P38 MAPK, p85 (pik3r), PI3K (complex), PIK3AP1, Pka, 
Pro-inflammatory Cytokine, Ras, TCR, TRIP10, Vegf, ZNFX1 
14 
Carbohydrate Metabolism, Small 
Molecule Biochemistry, 
Cell-To-Cell Signalling and 
Interaction 
4 
APOE, C5AR2, CARD9, chemokine, Ck2, CLEC4E, CST6, dihydrotestosterone, 
EMR1, FFAR4, FAK, G protein, Gsk3, Hdac, hemoglobin, hydroquinone, IL36G, 
Il3r, Jnk, KSR2, NFkB (complex), P2RY6, PELI2, Pik3r, PIK3R5, Pkc(s), RNA 
polymerase II, ROGDI, S1PR2, S1PR3, SIGIRR, SLC25A16, SLC6A9, SRL, 
ZFP36L2 
13 
Cell Death and Survival, Cellular 
Compromise, Neurological Dis-
ease 
#Bold denotes up-regulation and underscore denotes down-regulation of the gene. 
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the movement of leukocytes, especially neutrophils, from blood to the infected mammary tissue and milk. The 
initial up-regulation of TNFα in response to infection induces expression of the transcription factor EGR1 [47] 
which plays a key role in regulating the subsequent innate immune response by in turn increasing expression of 
the chemokines CXCL8, CXCL2 and CXCL6. Both Gram-positive and Gram-negative bacteria can induce EGR1 
expression in the mammary gland (Table S1). In the original gene expression studies analysed [17] [18], EGR1 
expression was increased to a similar extent at 20 - 24 h following E. coli or S. uberis infection (3.05- and 2.53- 
fold respectively). However the downstream responses to the two pathogens were much more extreme following 
E. coli [17] with increases in CXCL2, CXCL6 and CXCL8 ranging from 37- to 95-fold whereas the same 
chemokine genes only increased by 3-5- to 6-fold following exposure to S. uberis [18] (Table S1). 
Macrophages are the major cell type found in the milk of healthy bovine mammary glands while during infec-
tion an influx of neutrophils enters the infected site and plays a key role in the control of most mastitis patho-
gens [48]. IPA analysis showed that two pathways, Granulocyte Adhesion and Diapedesis Signalling and Ephrin 
Receptor Signalling seem particularly important. Granulocyte Adhesion and Diapedesis Signalling is crucial for 
granulocyte movement from blood vessels via the blood-udder barrier into the udder tissue [49] whereas Ephrin 
receptor signalling is important for mammary gland development and maintenance of function [50]. In addition, 
changes to lipid metabolism and/or lipid signalling through nuclear receptors are clearly also involved [11] [18]. 
Therefore only these three aspects of an immune response are discussed further here.  
4.2. Granulocyte Adhesion and Diapedesis Signalling 
Neutrophils derived from blood must experience a multistep process to reach the site of inflammation, including 
capture, rolling, activation and slow rolling, arrest, adhesion strengthening, intra luminal crawling followed by 
paracellular and transcellular migration [51]. Many of the DEGs identified in our study are known to facilitate 
this process (Figure 2). It is initiated by efficient interaction between selectins and their ligands on endothelial 
cells and neutrophils [52]. Increased TNFα, IL1β, C5a and histamine release could happen at a very early phase 
of mammary infection [53] [54]. These ligands then interact with their respective receptors TFNR, IL1R and 
HRH1 on the vascular endothelial cells, whose expression is also up-regulated. Such stimulation results in ex-
pression of the adhesion molecule P-selectin and VCAMs [55] [56]. P-selectin then interacts with P-selectin 
glycoprotein ligand 1 (PSGL-1) on the surface of neutrophils which makes them roll [57] and also primes neu-
trophil integrin activation for neutrophil adhesion during inflammation [58]. Integrin activation and normal func-
tion is crucial for neutrophils to develop firm adhesion after rolling. The key importance of integrinsin this process 
is shown by the development of the disease bovine leukocyte adhesion deficiency (BLAD) in Holstein cattle 
with a genetic deficiency of CD18, the β2-integrin chain [59].  
L-Selectin gene expression was also significantly induced during infection. Increased L-selectin expression by 
circulating neutrophils could facilitate their secondary tethering to an already rolling neutrophil through attach-
ing the PSGL-1 [60] [61]. PSGL-1 and L-selectin on the same neutrophil can interact and form a complex which 
is necessary to trigger integrin activation [62]. Neutrophil function was clearly associated with peripartum 
metritis and mastitis susceptibility [63], while glucocorticoid induced down-regulation of neutrophil L-selectin 
is regarded as an important reason for neutrophil dysfunction during the peripartum period [64].  
The bovine selectin genes (SELP, SELL, SELE) are located near each other in the putative mastitis-related 
QTL screened by Sodeland et al. [29]. The QTL peak location is at 44.91cM on BTA 16. In comparison be-
tween the two gene expression studies, SELL was up-regulated to a greater extent than SELP following E. coli 
infection (9.41- v 2.24-fold) [17] whereas the reverse was true for S. uberis (2.63- v 4.69-fold) [18]. The fold 
changes in both studies were, however, of a similar order of magnitude. This putative mastitis-related region was 
also reported in other QTL studies [65] [66]. Furthermore, we recently found that these three genes have a high 
degree of polymorphism by sequencing a population of UK Holstein cows (D.C. Wathes et al., unpublished 
data). Further study will focus on determining whether these genetic variations are indeed associated with masti-
tis incidence rates in dairy cows. 
Another important chromosomal region was located around 90 Mb on BTA6 containing the three chemokine 
genes CXCL8, CXCL2 and CXCL6. This area has been reported to show a significant relationship with mastitis 
in several different dairy cow populations [28] [29] [32]. All three chemokines signal via CXCR2 to activate 
neutrophils and subsequently promote their adhesion to the endothelium, before guiding them to move to sites of 
infection [67] [68]. CXCL8, released by epithelial cells, endothelial cells and macrophages is crucial for neu-
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trophil activation and recruitment and has been shown to have a significant association with dairy cow mastitis 
[69] [70]. CXCL2, released by mast cells and macrophages, is important to control the early stage of neutrophil 
recruitment during tissue inflammation [71]. Indeed, a recent gene expression study revealed that CXCL2 was 
among the few significantly changed genes after experimental intra-mammary infection with E. coli in lactating 
dairy cows treated with either the antibiotic cefapirin alone, in combination with the corticosteroid prednisolone 
or left untreated [72]. CXCL6 released by macrophages and epithelial cells exerts neutrophil-activating and an-
giogenic activities [73]. Besides, it also contributes to direct antibacterial activity during localized infection [74]. 
Together these different studies add weight to the key importance of CXCL2 and CXCR2 in influencing the 
ability of the mammary gland to overcome bacterial infections successfully. 
4.3. Ephrin Receptor Signalling Pathway and Its Role in Cytoskeletal Re-Organization 
Ephrin receptors constitute the largest family of tyrosine kinase receptors. They may be partly responsible for 
the phenotypic changes to the vascular endothelium in inflammation, which allows fluid and inflamed cells to 
pass from the vascular space into the interstitial tissues (Figure 3) [75]. During infection, many cytokines are 
released into the mammary gland causing changed contact and signal transmission among leukocytes and vas-
cular endothelial cells. Genes identified from our expression and association study indicated that this ephrin re-
ceptor signal can modify the cell’s cytoskeleton and adhesion when leukocytes and vascular endothelial cell at-
tract each other.  
A number of genes affecting ephrin receptor signalling (TNFα, IL1β, EphrinA1, SELE, VCAM-1, BCAR1 and 
ACTR3) were all up-regulated after intra-mammary infection with E. coli [17]. The cascade activation of the 
ephrin receptor signalling process seems clear. TNFα is the key cytokine increased sharply by E. coli, which 
then induces EphrinA1 in endothelial cells mediated through both p38MAPK and SAPK/JNKE pathways [76]. 
EphA2 activation by enhanced ephrinA1 stimulates leukocyte adhesion through: 1) inducing pro-inflammatory 
gene expression (SELE, VCAM-1) [77]; 2) increasing vascular permeability by moving the tight and adherens 
junction proteins VE-cadherin and claudin-5 away from the cell surface [78]; 3) activating FAK (the protein ty-
rosine kinase PTK 2) and Cas (the BCAR1 gene product) to regulate the actin cytoskeleton and cell migration 
[44] [79] [80]. VCAM-1 also activates Rac1 and leads to loosening of adherens junctions [81] and induces cy-
toskeletal re-organization. In contrast EhrinA1 and SELE did not show increased expression after S. uberis in-
tra-mammary infection [18] but instead only EphrinA4 was increased. One possible reason is that S. uberis in-
fection induced a lower level of TNFα at an earlier time point that the 20 h used in this study [82]. Discrepant 
ephrin receptor signalling in response to different pathogens may cause a different clinical response: this needs 
to be confirmed by further study. 
A significant increase in NRP2 and decrease in EphrinA5 after both types of bacterial infection [17] [18] in-
dicated an inhibition of RhoA function [83] [84]. RhoA inactivation regulates cell migration by promoting 
membrane protrusion and polarity [85]. Two other important Rho-GTPases Rac1 and Cdc42 were activated 
during infection, maybe through EPHB receptor signalling: these in turn affect the actin polymerizing complex 
ARP2/3 (product of theACTR3 gene) whose activation occurs through WAVE and WASP [45] [86]. ARP2/3 is 
crucial for cell migration by regulating the actin cytoskeleton [87] [88]. On the other hand, Rac1 and Cdc 42 ac-
tivation and RhoA inactivation can also stabilize actin and help maintain endothelial cell integrity [89], which 
indicated that small GTPases (RhoA, Rac1, Cdc42) play an important role to maintain balance between endo-
thelial barrier-stabilizing and increased permeability during inflammation. 
4.4. Fatty Acid Metabolism and Control of Neutrophil Diapedesis 
When dairy cows suffer mastitis, many genes involved in mammary gland lipid metabolism are down-regulated 
including FASN, SCP1, ACC, LPL, FABP3 and FABP4. Indeed, the majority of genes down-regulated by >1.5 
fold following S. uberis infection have been associated with lipid metabolism [18]. Of these, the two genes high-
lighted from the GWAS studies due to their associations with SCC were FASN and FABP4 [29] [33]. The 
chromosome area near FABP4 including the tandem FABP family of genes (Table 2) is thus of great interest. 
FABP4 belongs to a family of intra-cellular lipid chaperones which bind saturated and unsaturated fatty acids, 
eicosanoids and other lipids with high affinity. They then transport them to specific organelles including the mi-
tochondria for lipid oxidation, the nucleus for transcriptional regulation, theendoplasmic reticulum for mem-
brane synthesis or lipid droplets for storage [90]. FABPs also play a role in the production of lipid mediators in-
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cluding lipoxins (LXs), resolvins and protectins which have anti-inflammatory and pro-resolution properties [91] 
[92]. Both FABP3 and FABP4 are highly expressed in bovine mammary glands and FABP4 haplotypes have 
been associated with altering the proportions of saturated to unsaturated fatty acids in milk [93]. In human 
medicine FABP4 is attracting increasing attention as a clinical marker of metabolic disease involving insulin re-
sistance and inflammation [90]. 
FASN encodes fatty acid synthase, which plays a central role in de novo lipogenesis in mammals. Polymor-
phisms in the bovine FASN gene also contribute to variations in milk-fat content and influence the milk fat 
globule composition [94]. LXRs regulate FASN expression through direct interaction with the FAS promoter as 
well as through an indirect mechanism of activation of SREBP-1c expression [95]. The milk fat globule mem-
brane contains proteins including MFG-EGF8, which may mediate macrophage phagocytosis of apoptotic cells 
[96]. 
It is not yet clear why bacterial infection causes such a major shut-down in milk production including milk fat 
synthesis. One possibility would be to minimize energy loss into milk so sparing it for an effective immune re-
sponse [97]. In mammary tumours, restricted access to fatty acids reduces tumour proliferation as they are es-
sential for providing energy and for growth of the cell membrane [98]. Non-esterified fatty acids (NEFAs) and 
various fatty acid metabolites can also bind to and regulate the activity of PPARs, LXRs and HNF-4 [99]. A 
previous review indicated that FABP could combine with LTA (Leukotriene A) and stabilize it, which is helpful 
for the transport and transcellular biosynthesis of lipid mediators such as lipoxin A4 [100]. IPA analysis indi-
cated that the LPS/IL1 mediated inhibition of RXR function may weaken two other metabolic signalling path-
ways involving LXR/RXR and PPAR/RXR. Since activation of PPAR/RXR by fatty acids can reduce inflam-
matory responses by many mechanisms [101], inhibition of RXR function may enhance the inflammation signal 
in the early stages of infection. On the other hand, direct activation of lipoxin A4 receptor (ALX) by the lipid 
mediator LXA4 leads to cell-type-specific signalling events that stop neutrophil migration while at the same 
time stimulating macrophage activation [91]. Activated macrophages enhanced phagocytosis of apoptotic neu-
trophils in tissue, which can weaken the IL23/IL17/G-CSF cascade for neutrophil production from bone marrow 
[102]. Lipid mediators may thus function as a feedback system to control an excess influx of neutrophils and so 
avoid tissue damage. Further work is clearly required to determine exactly how polymorphisms in FABP4 and 
FASN contribute to a reduction in SCC in cows. 
5. Conclusion 
Through integrated analysis, this study has suggested that some common innate immune signalling pathways are 
involved in the response of the bovine mammary gland to different types of bacterial infection. These included 
granulocyte adhesion and diapedesis, ephrin receptor signalling, RhoA signalling and LPS/IL1 mediated inhibi-
tion of RXR function. These signalling pathways comprised a network regulating the activity of leukocytes es-
pecially neutrophils. Many promising genes in this network are known to control a series of neutrophil functions 
including adhesion (SELP, SELL), diapedsis (BCAR1, ACTR3), movement (CXCL2, CXCL6, CXCL8) and con-
trol (FABP, FASN). Polymorphisms in these genes may thus possibly contribute to differences in disease resis-
tance. When dairy cows suffer a mammary gland infection, the population of neutrophils in the milk and mam-
mary gland increases significantly. Neutrophils play key roles against pathogens via diapedesis, bacterial killing 
and apoptosis before a final return to homeostasis. Dysfunction of each step may cause greater damage to the 
mammary gland. Therefore, the timely and properly controlled movement of leukocytes to infection loci seems 
particularly important in achieving a good balance between pathogen elimination and excessive tissue damage. 
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Supporting Information 
Table S1. Summary list of 505 common genes with similar differential gene expression in mammary tissue after intra- 
mammary infection with E. coli or S. uberis. Data are from references [17] [18]. 
Gene symbol 
E. coli S. uberis 
P Fold change P Fold change 
TRAF3IP3 9.335E−06 −2.65 2.481E−06 −4.76 
LPIN1 5.972E−03 −1.74 5.295E−05 −3.83 
SLC31A2 1.933E−06 −2.58 4.977E−05 −3.38 
PEG3 1.865E−04 −1.93 2.232E−04 −3.26 
CD36 6.142E−10 −3.82 5.321E−05 −3.25 
SLC34A2 5.118E−10 −7.01 1.370E−04 −3.21 
SCD 2.713E−06 −2.25 2.693E−04 −3.11 
GPAM 2.251E−07 −6.12 1.583E−06 −2.97 
DNAJC12 1.111E−08 −4.66 4.942E−05 −2.95 
FABP4 3.177E−05 −2.89 2.853E−05 −2.93 
AAK1 2.566E−05 −1.68 1.490E−04 −2.92 
TPD52L1 2.175E−04 −1.59 8.359E−04 −2.90 
CLSTN1 5.645E−05 −1.91 1.222E−05 −2.87 
PNPLA2 1.543E−03 −1.58 1.895E−04 −2.86 
ASB11 7.854E−03 −2.04 8.502E−04 −2.83 
DHRS3 4.169E−04 −1.99 5.055E−04 −2.82 
CLMN 1.033E−06 −2.52 6.735E−05 −2.77 
FABP3 1.644E−05 −2.98 1.164E−04 −2.75 
COG2 1.221E−04 −1.51 3.650E−04 −2.75 
TMEM70 1.026E−07 −2.82 9.733E−05 −2.74 
ASPN 9.090E−06 −3.06 2.407E−03 −2.73 
RHPN2 3.520E−06 −2.71 5.479E−04 −2.73 
MUC15 2.826E−07 −2.26 3.685E−03 −2.70 
CIDEA 1.352E−06 −7.65 2.019E−04 −2.69 
ITGA6 8.882E−04 −1.56 1.222E−03 −2.67 
SLC17A5 3.714E−03 −1.58 9.864E−04 −2.65 
MOSPD1 6.276E−06 −2.61 1.756E−04 −2.63 
PER1 2.920E−03 −1.72 4.145E−05 −2.62 
STX8 1.417E−02 −1.57 2.552E−04 −2.62 
SLC16A1 5.595E−06 −2.71 1.415E−03 −2.62 
LPL 2.276E−07 −22.16 1.742E−04 −2.62 
PIK3C2G 1.457E−05 −1.68 8.524E−03 −2.60 
NELL2 2.098E−08 −5.15 1.865E−03 −2.60 
TMCC1 9.431E−05 −1.50 3.434E−03 −2.59 
PRKAR2B 9.905E−04 −1.70 1.500E−03 −2.58 
MRC2 1.465E−04 −1.96 2.044E−04 −2.56 
WIPI1 4.049E−03 −1.57 4.833E−05 −2.54 
MYBPC1 1.715E−07 −2.81 1.187E−03 −2.53 
DHCR24 2.414E−04 −1.66 1.184E−04 −2.53 
ABCG2 1.573E−04 −2.01 4.777E−04 −2.52 
SH3BP4 2.457E−08 −2.78 1.273E−04 −2.52 
FASN 2.401E−06 −4.39 8.828E−03 −2.51 
HNRPLL 3.186E−06 −2.13 1.970E−04 −2.51 
ABLIM1 7.130E−04 −1.59 2.732E−04 −2.51 
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PRKAA2 1.021E−03 −1.63 2.181E−04 −2.51 
TBC1D5 1.547E−03 −1.68 2.093E−03 −2.51 
VLDLR 4.323E−03 −1.95 2.147E−03 −2.50 
ITGB5 1.213E−02 −1.60 4.420E−03 −2.50 
EHF 8.660E−03 −1.50 2.412E−03 −2.50 
STK17A 3.119E−06 −2.03 1.001E−03 −2.49 
ORMDL3 8.373E−06 −2.00 2.788E−03 −2.49 
IDH1 1.560E−06 −2.36 7.090E−04 −2.48 
PPM1K 2.937E−05 −1.64 1.490E−03 −2.47 
RAPGEF1 1.894E−06 −1.89 5.957E−04 −2.47 
SOD1 6.628E−04 −2.21 2.019E−04 −2.47 
ESR1 2.182E−04 −1.57 1.010E−04 −2.47 
ANPEP 4.824E−07 −2.19 1.047E−04 −2.47 
PTHLH 1.068E−08 −9.73 5.374E−03 −2.46 
SORBS1 2.089E−04 −2.03 9.370E−03 −2.46 
KIAA1370 8.537E−08 −2.48 7.122E−04 −2.46 
AGRN 1.631E−04 −1.92 3.104E−04 −2.46 
BRP44L 3.224E−05 −2.51 1.871E−03 −2.46 
SERTAD4 1.191E−06 −2.99 2.089E−03 −2.45 
OSBPL1A 4.526E−07 −2.58 9.569E−04 −2.45 
RECQL5 2.916E−05 −1.73 4.821E−04 −2.45 
LRIG1 2.639E−05 −1.67 7.424E−03 −2.45 
EFNA5 3.052E−03 −1.52 6.255E−03 −2.45 
MMP15 3.190E−04 −1.57 2.981E−05 −2.45 
HSD11B1L 5.775E−04 −1.59 3.627E−03 −2.43 
COBLL1 2.420E−05 −2.20 1.890E−03 −2.43 
PRL 2.587E−04 −1.60 2.479E−03 −2.43 
SLC9A3R2 1.483E−04 −1.56 4.334E−03 −2.42 
ZNF330 3.556E−04 −1.86 9.074E−04 −2.42 
GP2 5.675E−03 −1.77 7.272E−03 −2.42 
GALM 1.447E−07 −6.95 2.480E−04 −2.42 
NFIB 1.899E−03 −1.61 5.204E−03 −2.41 
IGFBP5 1.769E−05 −2.50 1.214E−03 −2.41 
FAM46B 1.360E−04 −1.61 1.457E−04 −2.41 
GGT1 7.573E−05 −1.85 1.449E−03 −2.41 
RASSF4 3.602E−06 −3.29 5.306E−03 −2.41 
MTHFR 7.328E−04 −1.55 3.461E−03 −2.40 
SPTBN1 3.971E−04 −1.57 2.440E−04 −2.40 
BDH2 1.026E−04 −1.82 5.961E−03 −2.40 
BAZ2B 3.091E−04 −1.62 6.260E−03 −2.40 
KLHL21 1.051E−04 −1.52 9.846E−04 −2.39 
HLF 4.224E−07 −2.97 5.134E−03 −2.39 
CD109 2.074E−03 −1.98 4.360E−03 −2.39 
DLG3 7.619E−04 −1.55 4.292E−03 −2.39 
ANG 2.699E−06 −3.21 4.176E−03 −2.37 
GTF2H5 1.433E−02 −1.56 2.333E−03 −2.37 
EMX2 1.633E−03 −1.55 5.618E−03 −2.37 
CRISPLD2 8.866E−07 −2.13 1.374E−03 −2.37 
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GRID1 4.686E−05 −1.73 4.128E−04 −2.36 
NOV 8.641E−05 −2.10 4.874E−03 −2.36 
SDC2 1.457E−06 −3.23 5.085E−05 −2.36 
CYB5D2 1.795E−04 −1.94 1.651E−03 −2.36 
ZBTB4 5.760E−05 −1.65 8.425E−03 −2.36 
TIMM8B 1.269E−02 −1.79 8.813E−05 −2.35 
MIB2 3.084E−05 −1.75 3.074E−03 −2.35 
GABRB3 3.532E−03 −1.51 2.399E−03 −2.35 
TENC1 2.248E−05 −1.97 6.986E−04 −2.34 
ALDH18A1 7.008E−07 −1.88 2.358E−03 −2.34 
ENPP4 2.721E−07 −2.50 9.008E−03 −2.34 
TMEM9 7.726E−04 −1.51 4.526E−03 −2.33 
GUCY2D 2.993E−03 −1.52 3.144E−04 −2.33 
PARD3B 3.810E−05 −1.66 4.392E−03 −2.33 
ASB8 2.329E−03 −1.64 7.994E−04 −2.32 
ROGDI 4.294E−05 −2.08 6.599E−03 −2.32 
BEX2 4.654E−04 −1.62 9.350E−04 −2.30 
FAM110A 9.800E−04 −1.62 1.075E−03 −2.30 
PATZ1 2.338E−02 −1.58 9.499E−03 −2.30 
TNRC6C 1.513E−04 −1.72 6.307E−04 −2.30 
FXYD2 1.151E−06 −1.88 1.609E−03 −2.30 
FXYD1 4.829E−03 −1.94 7.062E−03 −2.30 
COL6A1 3.349E−05 −1.63 4.749E−03 −2.30 
HES1 2.168E−02 −1.77 4.650E−03 −2.30 
STARD13 1.808E−03 −1.61 1.833E−03 −2.30 
FXYD6 6.317E−04 −1.86 3.714E−03 −2.29 
GPR162 9.402E−04 −1.66 3.412E−03 −2.28 
CHRNB4 1.286E−04 −1.69 6.077E−03 −2.27 
CGN 4.160E−04 −1.71 4.032E−03 −2.27 
GNAS 2.585E−04 −1.52 9.458E−03 −2.27 
PRKCA 1.503E−05 −1.58 6.079E−03 −2.27 
SHF 7.071E−04 −1.54 7.206E−04 −2.27 
ACSS2 4.862E−06 −2.48 7.371E−03 −2.27 
KCNMA1 4.481E−05 −1.64 3.408E−03 −2.27 
CLDN16 8.120E−03 −1.58 7.603E−04 −2.26 
MAGIX 5.245E−04 −1.53 5.549E−03 −2.26 
CDH17 2.611E−04 −1.54 9.139E−05 −2.26 
XDH 2.213E−03 −1.55 8.817E−03 −2.25 
CYFIP2 4.761E−04 −1.98 3.079E−04 −2.25 
ACACA 8.734E−08 −2.52 6.830E−03 −2.25 
DPYD 3.994E−05 −2.32 1.369E−03 −2.25 
FMOD 6.440E−03 −1.81 5.443E−03 −2.25 
VGLL1 1.362E−02 −1.55 2.613E−03 −2.25 
NT5E 8.932E−03 −1.87 7.080E−03 −2.24 
TLN2 9.384E−06 −1.90 2.325E−03 −2.24 
SLC25A21 6.866E−08 −8.53 4.211E−03 −2.24 
CBFA2T3 7.948E−06 −2.06 2.934E−03 −2.23 
TREX1 7.512E−03 −1.77 9.250E−03 −2.23 
X. Chen et al. 
 
 380 
Continued 
TRPM4 7.061E−04 −1.70 4.594E−03 −2.22 
OS9 2.494E−05 −1.61 5.856E−03 −2.22 
PMM2 3.968E−05 −1.60 3.819E−03 −2.22 
EFHC1 4.414E−08 −3.64 4.868E−03 −2.22 
KHK 2.421E−05 −2.18 2.390E−03 −2.22 
SLC6A3 2.766E−05 −1.56 8.602E−03 −2.21 
TOP3B 6.568E−04 −1.56 2.844E−03 −2.21 
FCHSD1 1.205E−05 −1.61 2.894E−03 −2.21 
CST3 2.151E−02 −1.65 2.854E−03 −2.21 
MAGED2 4.760E−04 −1.51 6.760E−03 −2.21 
CST6 5.042E−04 −1.52 6.631E−03 −2.21 
FGFRL1 1.201E−06 −2.27 3.069E−03 −2.20 
ACO1 1.120E−04 −1.81 7.728E−03 −2.20 
CUL7 3.015E−05 −1.75 3.656E−03 −2.19 
CLEC3B 4.206E−04 −2.38 4.631E−03 −2.18 
PON3 2.001E−02 −1.97 5.873E−04 −2.15 
HSF1 1.753E−05 −1.61 7.465E−03 −2.15 
RAB7A 1.967E−05 1.54 3.073E−03 2.15 
ZDHHC2 6.175E−06 2.74 6.004E−03 2.16 
TSPO 1.888E−06 3.40 6.837E−03 2.16 
CA2 5.311E−03 2.07 6.661E−03 2.16 
SMU1 4.949E−06 1.91 9.046E−03 2.17 
ZNF677 1.070E−03 1.51 8.562E−03 2.17 
ZFYVE26 3.997E−04 1.54 4.610E−03 2.18 
CDV3 7.402E−04 1.74 6.053E−03 2.18 
PLEKHO1 1.524E−08 2.99 8.724E−03 2.19 
MIA3 8.766E−04 1.53 5.597E−03 2.19 
RELB 3.622E−06 2.08 8.819E−03 2.19 
NRP2 6.655E−04 1.83 2.940E−03 2.19 
GRHPR 1.439E−05 2.11 4.284E−03 2.20 
SERPINH1 2.098E−04 1.82 4.659E−03 2.20 
MAD2L2 3.173E−03 1.51 1.564E−03 2.20 
TLR4 1.043E−04 2.24 6.966E−03 2.21 
PCNA 7.218E−05 1.53 5.080E−04 2.21 
CAPZA2 8.058E−05 1.60 8.863E−03 2.21 
SRL 2.891E−03 1.51 1.051E−03 2.21 
BECN1 3.667E−04 1.65 6.811E−03 2.21 
COX10 2.089E−05 2.03 3.098E−03 2.22 
WHSC1L1 5.287E−04 1.59 6.964E−03 2.22 
SRI 2.066E−07 3.16 7.708E−03 2.22 
CA8 1.917E−02 1.59 8.083E−03 2.23 
GNAI2 8.706E−07 2.10 7.527E−03 2.24 
IFNAR2 2.013E−06 2.99 1.245E−03 2.24 
GRB2 5.888E−06 1.62 3.736E−03 2.24 
MIER1 7.274E−03 1.51 2.500E−03 2.24 
PEX11A 1.165E−03 2.05 8.955E−03 2.24 
DAZAP2 8.313E−06 1.68 4.023E−03 2.25 
TWISTNB 1.188E−05 1.66 2.891E−03 2.25 
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SNRPB 2.010E−03 1.56 3.837E−03 2.25 
SLC3A2 1.658E−03 1.53 4.403E−03 2.25 
CTSZ 1.306E−07 3.10 1.307E−03 2.25 
MOCS2 1.362E−03 1.73 3.602E−03 2.25 
MFAP3 3.179E−03 1.67 3.828E−03 2.26 
VARS 2.488E−05 1.82 2.930E−03 2.26 
SEC11A 1.321E−06 2.30 3.544E−03 2.26 
HSPD1 9.354E−06 2.64 9.238E−03 2.26 
FAS 8.817E−04 2.14 1.836E−03 2.26 
CRNKL1 1.488E−04 1.62 4.508E−03 2.26 
FARSB 1.613E−05 1.66 4.306E−03 2.26 
ARF4 1.041E−08 3.69 4.812E−03 2.27 
DPH5 1.484E−05 2.09 8.743E−03 2.27 
MRPL12 6.693E−03 1.53 8.579E−03 2.27 
CDK5RAP3 1.873E−04 1.50 1.936E−03 2.27 
VASP 1.438E−07 2.28 8.285E−03 2.27 
PHF11 1.431E−07 2.22 3.035E−03 2.28 
HRH1 8.081E−03 2.65 9.276E−03 2.28 
S100A11 5.258E−05 2.05 6.033E−03 2.28 
KLF2 2.040E−04 1.82 3.530E−03 2.28 
KCTD10 7.294E−05 1.68 1.770E−03 2.28 
NRAS 1.649E−04 1.69 7.555E−03 2.28 
PRDX1 7.507E−03 1.51 1.301E−03 2.29 
VCP 5.817E−05 1.79 1.632E−03 2.29 
ZFAND3 5.642E−05 1.87 1.562E−03 2.29 
SKIL 1.472E−03 1.79 1.215E−03 2.29 
ZSWIM6 4.863E−03 1.50 8.707E−03 2.30 
CDH5 1.068E−04 1.94 2.921E−03 2.30 
FSTL1 1.039E−02 1.56 5.136E−04 2.30 
RNF8 1.296E−03 1.68 5.728E−03 2.30 
ZMAT2 2.119E−04 1.54 8.800E−04 2.31 
RBMS1 2.548E−06 2.01 6.531E−03 2.31 
SNRPG 1.034E−02 1.55 4.420E−03 2.31 
PSMD14 3.426E−07 2.28 6.370E−03 2.31 
SLC25A16 7.479E−03 1.52 1.501E−04 2.31 
KPNA3 1.404E−04 1.75 6.568E−04 2.32 
PDIA4 3.298E−03 1.53 5.377E−03 2.32 
SPRY1 1.586E−04 2.27 8.901E−04 2.32 
PSMB2 2.769E−03 1.75 3.871E−03 2.32 
ATP13A3 2.832E−03 1.56 6.209E−04 2.33 
ENPP2 2.497E−02 1.56 6.808E−03 2.33 
RNPS1 7.156E−06 1.83 2.321E−03 2.33 
DDX27 1.147E−04 1.63 4.456E−04 2.33 
PRMT1 1.998E−03 1.52 7.071E−03 2.33 
DBI 7.271E−04 1.67 4.683E−04 2.33 
FKBP3 1.764E−03 1.53 4.260E−03 2.33 
SULF2 1.815E−05 1.89 3.735E−03 2.33 
PSMB8 4.842E−05 2.47 7.027E−03 2.34 
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RARS 2.396E−06 1.98 2.038E−03 2.34 
GOT2 6.968E−03 1.60 1.631E−03 2.34 
ME1 9.092E−03 1.68 6.852E−03 2.34 
RBBP5 1.153E−02 1.59 1.321E−03 2.34 
CXCR4 6.181E−06 4.51 4.472E−03 2.34 
RAP2B 2.668E−05 1.77 2.376E−03 2.34 
USP12 1.689E−06 2.09 9.603E−04 2.35 
DLG5 1.250E−03 1.82 2.159E−04 2.35 
CDKN1A 7.194E−05 5.18 4.882E−03 2.35 
FBXL5 9.989E−06 1.97 2.323E−04 2.35 
SLC6A9 1.106E−05 2.16 6.493E−03 2.35 
TAP1 1.197E−06 2.59 1.247E−03 2.35 
IFIT5 8.429E−06 2.24 2.574E−05 2.35 
RBM22 4.014E−06 1.84 2.014E−03 2.35 
SOAT1 5.305E−06 2.54 1.341E−03 2.35 
EIF4E 2.237E−05 1.54 2.108E−03 2.35 
FAM103A1 1.258E−06 2.09 9.365E−03 2.35 
ANTXR2 2.796E−06 2.41 3.734E−03 2.35 
RBM14 4.155E−05 1.76 6.572E−04 2.35 
CTSB 2.620E−07 2.80 3.950E−03 2.36 
ME2 1.431E−07 4.44 3.003E−03 2.36 
COTL1 1.094E−07 3.71 1.556E−04 2.36 
HSP90AB1 1.240E−07 3.63 6.663E−04 2.36 
PSME3 4.748E−04 1.81 2.798E−03 2.36 
PSMB4 1.045E−04 1.76 1.372E−04 2.36 
DEGS1 1.503E−05 1.62 9.150E−04 2.36 
ZC3HAV1 1.779E−07 3.50 1.930E−03 2.37 
IER3 1.614E−04 2.86 5.038E−03 2.37 
TACSTD2 7.811E−09 10.88 1.470E−03 2.37 
SYNCRIP 3.443E−03 1.67 1.880E−03 2.37 
ARPC5 2.118E−05 1.76 5.749E−04 2.37 
CDC42SE2 3.071E−07 1.99 6.058E−04 2.37 
DNAJC3 3.095E−05 1.81 4.416E−03 2.37 
PES1 1.935E−05 1.54 4.557E−03 2.38 
FBXW2 3.293E−06 2.08 4.617E−05 2.38 
DPH2 3.106E−05 1.77 1.713E−03 2.38 
HSPA4 4.265E−05 1.85 2.294E−03 2.38 
PICALM 3.741E−04 1.82 2.153E−03 2.38 
AMMECR1L 3.784E−04 1.83 2.581E−03 2.38 
CAP1 8.545E−06 2.04 1.670E−03 2.39 
CAPZA1 3.759E−04 1.53 1.233E−03 2.39 
TPM4 7.875E−06 2.22 4.105E−03 2.39 
TARS 3.153E−04 1.78 5.801E−04 2.39 
IL4R 2.288E−05 2.33 3.517E−03 2.40 
PTGES3 3.662E−06 1.78 1.549E−04 2.40 
YWHAG 3.233E−06 2.07 1.174E−03 2.40 
BTG1 6.532E−08 2.70 8.086E−03 2.40 
GLUD1 2.363E−04 1.76 1.060E−03 2.40 
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EBNA1BP2 1.131E−06 2.38 2.017E−03 2.40 
XPO6 1.902E−07 2.11 1.043E−03 2.41 
JUNB 4.860E−08 5.21 1.237E−04 2.41 
DNTTIP2 2.495E−03 1.57 4.512E−03 2.41 
STX6 9.094E−04 1.79 3.418E−03 2.41 
YWHAZ 7.522E−04 1.64 3.060E−03 2.42 
PARP14 2.667E−08 3.12 4.282E−03 2.42 
CEBPB 1.907E−07 2.98 4.832E−04 2.42 
RNF149 1.105E−06 2.10 3.332E−04 2.42 
RPS6KA3 4.263E−04 2.89 1.932E−03 2.42 
APEX1 4.864E−04 1.53 3.798E−03 2.42 
IL10RB 5.428E−10 3.62 1.152E−03 2.42 
EAF1 2.498E−05 2.25 4.242E−03 2.42 
SLC39A6 9.024E−04 1.79 4.306E−03 2.42 
GSPT1 7.421E−04 1.59 5.596E−03 2.42 
PKIG 5.177E−03 1.66 2.364E−03 2.42 
IQGAP1 2.597E−06 1.84 3.464E−03 2.42 
ZNF281 6.625E−07 2.97 2.326E−03 2.42 
PGS1 3.224E−08 3.51 5.726E−03 2.42 
PSMA1 1.157E−06 2.25 1.928E−03 2.42 
TNFRSF1A 1.580E−07 2.36 4.401E−05 2.42 
PARP9 1.020E−09 4.19 1.971E−03 2.43 
LYPLA1 8.530E−07 2.47 1.166E−03 2.43 
TRIM37 5.108E−06 2.07 6.723E−03 2.44 
PIK3AP1 3.097E−06 3.03 4.637E−05 2.44 
SPG21 7.031E−07 2.39 1.963E−03 2.44 
TSFM 2.131E−04 1.71 6.485E−03 2.44 
MAPRE1 1.438E−04 1.58 3.229E−04 2.44 
CD44 1.031E−09 6.88 2.314E−03 2.44 
ABL1 5.007E−03 1.72 5.638E−04 2.45 
PSMA2 2.987E−05 2.06 1.131E−04 2.45 
LEO1 7.417E−04 1.60 9.995E−04 2.45 
PSMA5 7.350E−04 1.61 1.087E−03 2.45 
PREP 1.248E−05 1.96 3.760E−04 2.45 
TGFBI 1.135E−07 5.74 2.525E−03 2.46 
CD164 3.472E−04 1.90 8.728E−05 2.46 
UNC93A 1.108E−03 1.65 1.030E−04 2.46 
GPBP1 1.232E−03 1.55 4.448E−03 2.46 
GNAI3 3.707E−06 2.24 1.525E−04 2.46 
RAB5C 1.378E−05 1.60 2.148E−04 2.46 
MAPK6 9.939E−04 1.64 9.782E−04 2.47 
CDO1 3.795E−06 2.69 2.869E−05 2.47 
ASNSD1 3.104E−05 1.98 4.060E−03 2.47 
NFKB2 4.783E−07 5.02 3.360E−03 2.47 
GAPDH 7.628E−11 3.76 7.598E−06 2.47 
TXN 1.079E−05 2.98 1.756E−03 2.47 
RAC1 2.337E−09 2.70 7.588E−05 2.48 
CCNL1 9.457E−05 2.07 4.973E−03 2.48 
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ADAM19 4.315E−08 3.43 2.584E−03 2.48 
SH3RF1 5.814E−05 2.48 2.488E−03 2.49 
LCP1 4.898E−10 7.99 1.107E−03 2.49 
TNIP1 8.206E−08 4.14 2.118E−03 2.50 
SKAP2 7.477E−08 2.77 8.721E−04 2.50 
GNAI1 1.874E−02 1.70 1.962E−03 2.50 
LETM1 4.601E−04 1.77 1.214E−04 2.50 
EIF2AK2 7.598E−06 2.81 9.093E−04 2.50 
PYGL 2.604E−04 2.37 4.496E−04 2.50 
SPCS3 1.244E−04 1.81 3.180E−03 2.50 
APBB1IP 2.283E−07 3.71 7.966E−04 2.50 
MPEG1 2.572E−04 2.12 3.364E−04 2.51 
BCL6 7.592E−04 1.78 7.308E−04 2.51 
TAPBP 1.496E−06 1.98 1.392E−04 2.51 
MSN 1.163E−06 2.19 3.891E−03 2.51 
GFPT2 9.933E−05 2.93 1.238E−03 2.52 
B4GALT5 1.215E−03 1.93 7.578E−05 2.53 
KIAA0020 3.397E−06 1.80 7.147E−03 2.53 
CNN2 2.288E−06 2.87 6.993E−04 2.53 
ZNFX1 9.714E−05 1.81 9.497E−04 2.53 
PLAC8 5.976E−05 3.96 2.621E−04 2.53 
NINJ1 1.400E−05 2.55 3.734E−04 2.53 
EGR1 3.004E−05 3.05 3.466E−03 2.53 
BCAR1 2.774E−03 1.66 3.061E−05 2.54 
CD53 1.136E−08 7.50 4.943E−05 2.54 
EIF2S1 1.423E−05 1.90 6.079E−04 2.54 
XPNPEP1 3.125E−04 1.51 9.498E−05 2.55 
ETF1 2.442E−05 2.31 2.361E−03 2.55 
CHSY1 1.503E−03 1.87 2.960E−05 2.56 
CCT2 4.623E−07 2.35 3.598E−04 2.56 
RAN 1.566E−06 1.93 8.518E−05 2.56 
MTDH 2.474E−06 2.25 6.644E−05 2.58 
FTH1 3.253E−08 2.25 4.562E−03 2.58 
YARS 2.835E−03 1.70 3.182E−04 2.59 
CALCRL 6.151E−03 2.35 3.593E−04 2.59 
CD14 5.675E−05 2.31 1.200E−03 2.59 
LAP3 3.410E−07 2.39 1.532E−04 2.59 
DGAT2 7.155E−06 2.49 4.294E−03 2.59 
RIPK2 1.435E−04 1.77 1.281E−03 2.59 
SLC39A1 1.189E−05 1.86 3.585E−04 2.59 
ELL 1.914E−04 1.63 6.155E−05 2.59 
ATP1B3 1.059E−05 1.99 3.262E−04 2.59 
HK3 3.267E−06 2.56 4.901E−03 2.60 
PFN1 2.672E−05 2.00 6.449E−05 2.60 
PSME2 7.783E−05 2.25 3.356E−04 2.60 
TNFRSF6B 4.761E−08 16.81 3.746E−03 2.61 
SLC11A2 1.086E−04 2.94 2.950E−04 2.61 
PTGS2 8.825E−04 2.98 3.098E−03 2.62 
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ZNF259 1.571E−08 4.09 3.524E−05 2.62 
CTTN 2.266E−05 1.82 1.846E−05 2.62 
BASP1 1.025E−09 4.61 9.302E−04 2.62 
PDIA3 7.205E−04 1.54 2.188E−04 2.62 
TRIM25 2.671E−03 2.10 5.664E−05 2.63 
KLF10 3.607E−05 2.74 6.115E−05 2.63 
SELL 3.699E−09 9.41 4.881E−05 2.63 
REXO2 9.668E−03 1.51 1.273E−05 2.64 
CLEC2D 2.334E−05 2.51 4.824E−04 2.64 
PLSCR1 3.972E−04 1.94 1.051E−03 2.65 
RSL1D1 1.747E−06 2.00 1.205E−04 2.65 
SLCO4A1 2.121E−03 2.05 7.528E−05 2.65 
TSR1 1.721E−06 2.04 2.136E−03 2.65 
MTHFD2 4.432E−05 3.47 4.381E−04 2.66 
FBL 3.675E−04 1.75 1.039E−03 2.66 
DDX21 7.622E−04 1.91 7.045E−04 2.66 
CCT3 8.468E−08 2.61 9.208E−04 2.67 
UGDH 1.774E−08 5.49 7.768E−04 2.68 
AATF 1.800E−08 2.60 1.649E−03 2.68 
PPP1R3C 2.221E−02 1.73 5.321E−04 2.68 
TUBB6 9.833E−06 2.01 7.009E−04 2.69 
RAC2 3.791E−07 3.47 9.361E−05 2.69 
ACTR3 1.263E−07 2.49 1.890E−05 2.69 
HIF1A 5.376E−03 1.56 1.820E−04 2.70 
TRIP10 1.781E−04 1.72 1.609E−04 2.71 
TGIF1 2.745E−09 4.70 2.080E−03 2.72 
IL18 4.383E−06 3.95 4.682E−03 2.73 
WTAP 6.029E−07 3.51 1.929E−03 2.73 
TLR2 3.800E−06 5.08 7.792E−04 2.73 
IL13RA1 6.900E−08 4.46 1.827E−04 2.74 
RAB8B 4.100E−06 2.65 8.962E−05 2.74 
DNAJB1 1.964E−04 1.87 7.543E−05 2.74 
WARS 2.972E−07 3.75 1.061E−04 2.75 
NPM1 1.562E−06 1.91 6.562E−07 2.75 
MKNK1 5.162E−07 4.35 8.468E−04 2.76 
PPP2R3C 1.962E−07 2.84 9.361E−04 2.76 
DENND2D 2.413E−05 2.11 3.423E−04 2.76 
CREM 4.351E−07 2.86 7.710E−05 2.77 
CFLAR 4.988E−05 3.68 5.098E−05 2.78 
IL1RAP 7.593E−08 12.26 1.450E−03 2.79 
SMAD3 3.316E−04 1.88 8.698E−05 2.79 
CTSH 1.083E−08 4.37 4.274E−04 2.79 
PTPRC 2.453E−07 3.01 7.043E−04 2.80 
EFHD2 2.703E−04 2.29 5.093E−05 2.80 
MYC 1.141E−05 2.77 1.663E−03 2.80 
SPINT1 7.591E−07 1.98 5.885E−04 2.81 
TNFAIP6 1.118E−05 5.40 2.746E−04 2.82 
TREM1 2.224E−12 18.55 1.376E−03 2.82 
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PDK4 2.015E−05 4.29 2.598E−03 2.82 
CD48 2.297E−07 7.34 3.839E−03 2.83 
GNG5 7.598E−05 2.21 1.247E−04 2.83 
IER5 6.385E−09 4.52 9.829E−06 2.83 
PLAU 6.120E−07 3.15 7.076E−04 2.84 
ARG2 5.740E−07 9.36 8.823E−04 2.85 
NCL 1.458E−05 1.67 2.094E−05 2.85 
SOCS3 1.981E−07 10.69 7.538E−05 2.85 
CKAP4 7.588E−09 2.68 4.360E−04 2.85 
FGL2 6.026E−07 3.84 2.331E−03 2.87 
NOLC1 1.100E−04 1.73 3.343E−05 2.87 
MFAP1 2.666E−05 1.94 3.058E−05 2.87 
STAT3 3.920E−06 3.56 7.192E−04 2.87 
ITGAV 8.828E−05 3.04 7.350E−04 2.89 
MAP3K8 4.641E−08 6.06 2.059E−03 2.90 
ZFP36L2 2.083E−07 2.75 3.291E−04 2.91 
OLR1 5.814E−08 10.47 8.629E−04 2.91 
EHBP1L1 2.585E−07 2.76 8.502E−04 2.92 
F13A1 6.370E−05 3.35 8.009E−04 2.92 
VCAM1 1.063E−05 3.70 3.358E−05 2.96 
PDPN 3.439E−07 5.14 8.817E−04 3.01 
FAM49B 1.473E−09 4.03 1.273E−03 3.01 
HPRT1 4.758E−09 2.83 2.945E−05 3.01 
IL10RA 7.765E−06 2.80 2.024E−04 3.06 
CXCL2 2.015E−09 94.97 4.469E−04 3.08 
IL18BP 4.330E−13 19.99 2.502E−05 3.09 
CALR 1.175E−03 1.51 5.533E−05 3.10 
PHC2 3.577E−05 1.94 4.503E−03 3.12 
HSPA8 2.282E−04 1.97 1.316E−04 3.15 
MARCKS 1.100E−06 3.38 2.273E−04 3.16 
PSTPIP2 1.473E−09 9.30 8.168E−04 3.20 
SPI1 1.665E−09 8.31 2.253E−03 3.22 
PTX3 6.138E−05 14.95 2.374E−05 3.26 
CCL20 1.492E−03 4.25 3.011E−04 3.28 
GNL3 6.264E−04 1.51 8.200E−04 3.32 
IL1R2 1.442E−07 21.40 4.001E−04 3.39 
THBS1 1.473E−02 1.92 3.659E−04 3.44 
CASP4 8.023E−09 5.76 2.035E−04 3.48 
LDHA 2.002E−10 7.36 2.267E−04 3.51 
ERRFI1 1.041E−06 3.51 9.545E−06 3.53 
CD9 1.353E−06 1.87 3.570E−06 3.66 
ZFP36 1.841E−07 3.88 1.258E−04 3.66 
MXD1 1.177E−07 4.43 2.527E−05 3.76 
FOS 1.259E−07 7.79 1.195E−05 3.78 
CEBPD 1.642E−06 5.41 9.992E−05 3.93 
BCL3 1.501E−05 2.11 1.060E−04 3.94 
CXCL6 3.538E−10 36.81 6.165E−04 4.01 
CD69 6.630E−06 7.08 1.879E−03 4.04 
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SDCBP 1.953E−06 2.14 3.513E−05 4.06 
LTF 3.092E−04 2.16 2.757E−07 4.08 
CD55 7.343E−11 18.46 2.532E−04 4.20 
EIF4A1 7.736E−08 2.11 7.705E−05 4.25 
BTG2 1.734E−03 1.93 8.071E−04 4.37 
NFKBIA 2.947E−05 3.40 5.504E−05 4.48 
IL1RN 4.433E−09 30.47 7.596E−05 4.54 
TGM3 1.511E−10 34.32 1.288E−03 4.65 
CCR1 1.818E−12 22.15 1.624E−04 4.67 
TIMP1 5.574E−07 9.62 4.653E−05 4.68 
SELP 2.566E−03 2.24 1.030E−04 4.69 
FSCN1 1.983E−04 1.59 1.680E−05 4.69 
RRAD 1.179E−04 2.54 1.228E−04 4.74 
IL6 1.157E−03 7.04 5.230E−04 4.89 
CXCL8 1.015E−09 82.99 1.332E−04 5.64 
PLAUR 5.943E−04 2.24 5.168E−05 5.71 
S100A2 4.128E−10 12.75 1.518E−04 5.86 
EMR1 2.942E−11 63.30 8.899E−05 6.02 
CTSC 2.926E−11 8.53 1.140E−05 6.51 
SRGN 8.525E−11 10.29 8.856E−06 6.70 
LOC508666 6.325E−04 4.39 2.602E−05 6.84 
LYZ 2.947E−07 9.10 8.344E−05 6.93 
SLC2A3 7.758E−06 4.59 1.488E−04 7.64 
BCL2A1 1.008E−08 9.25 9.684E−05 8.12 
S100A12 1.315E−12 121.83 4.831E−04 9.02 
BIRC3 1.024E−06 9.27 2.839E−05 9.61 
MARCKSL1 4.891E−06 2.49 1.610E−06 9.83 
S100A9 1.288E−15 262.26 3.313E−05 12.22 
CCL2 1.797E−06 11.15 2.960E−05 20.21 
 
Table S2. Top 10 signalling pathways from IPA among the 505# common DEGs altered by experimental infections with 
both E. coli and S. uberis (all with P < 10E−6). 
Canonical pathways Molecules Ratio 
IL-10 Signalling 16 2.05E−01 
Granulocyte Adhesion and Diapedesis 24 1.32E−01 
LXR/RXR Activation 19 1.37E−01 
IL-6 Signalling 18 1.45E−01 
Glucocorticoid Receptor Signalling 26 8.7E−02 
Ephrin Receptor Signalling 21 1E−01 
Agranulocyte Adhesion and Diapedesis 21 1.09E−01 
PPARα/RXRα Activation 20 1E−01 
Hepatic Fibrosis/Hepatic Stellate Cell Activation 17 1.1E−01 
Leukocyte Extravasation Signalling 20 9.52E−02 
#504 Genes with known IPA-eligible human and rodent orthologs were considered. 
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Table S3. Primary function analysis with IPA for the 505# common DEGs altered by both experimental infections with both 
E. coli and S. uberis (all with P < 1E−7). 
Name Molecules 
Diseases and Disorders 
Inflammatory Response 164 
Connective Tissue Disorders 112 
Molecular and Cellular Functions 
Cell Death and Survival 246 
Cellular Growth and Proliferation 249 
Cellular Movement 172 
Cellular Function and Maintenance 187 
Cellular Development 223 
Physiological System Development and Function 
Immune Cell Trafficking 110 
Organismal Survival 182 
Tissue Morphology 155 
Hematological System Development and Function 165 
Tissue Development 149 
#504 Genes with known IPA-eligible human and rodent orthologs were considered. 
 
Table S4. Summary list of 93 significant SNPs associated with somatic cell count in seven different populations of dairy 
cows and 1635 genes located 2 Mbp around them#. 
SNP+ BTA Symbols of nearby genes located within 2 Mbp 
rs41637122 1 APP, ATP5J, GABPA, JAM2, MRPL39 
BTA-47902 2 ACTR3, GPR39, LYPD1, MGAT5, NCKAP5, SLC35F5 
Hap-
map29674-BTA-16031
0/rs110139290 
2 ARHGAP15, KYNU, LRP1B 
rs110491622  ABCB11, B3GALT1, BBS5, CCDC173, CERS6, DHRS9, FASTKD1, G6PC2, KBTBD10, KLHL23, LRP2, METTL5, MYO3B, NOSTRIN, PHOSPHO2, PPIG, SPC25, SSB, STK39, UBR3, XIRP2 
rs29025784 2 
TNS1, AAMP, ABCB6, NKZF1, ARPC2, ASIC4, ATG9A, BCS1L, C2H2ORF24, C2ORF17, C2orf62, 
CCDC108, CDK5R2, CHPF, CRYBA2, CTDSP1, CXCR2, CXCR2, CYP27A1, DES, DNAJB2, 
DNPEP, EPHA4, FEV, GLB1L, GMPPA, GPBAR1, IHH, INHA, MGC157327, NHEJ1, OBSL1, 
PLCD4, PNKD, PRKAG3, PTPRN, RECS1, RESP18, RNF25, RQCD1, SLC11A1, SLC23A3, 
SLC4A3, SPEG, STK11IP, STK16, STK36, TMEM198, TTLL4, TUBA1D, TUBA4A, USP37, VIL1, 
WNT10A, WNT6, ZFAND2B, ZNF142 
rs41622740/ 
rs41622742  2 ACADL, CPS1, CRYGF, ERBB4, KANSL1L, LANCL1, MAP-2, MYL1, PTH2R, RPE, UNC80 
rs29020694 4 ING3, CPED1, WNT16, FAM3C, PTPRZ1, AASS, FEZF1, CADPS2, TAS2R16, SLC13A1, IQUB, NDUFA5, ASB15, LMOD2, WASL, HYAL4, GPR37, POT1 
rs41590209 4 
AASS, ASB15, CADPS2, CPED1, FAM3C, FEZF1, GPR37, HYAL4, , NG3, IQUB, LMOD2, 
NDUFA5, POT1, PTPRZ1, SLC13A1, TAS2R16, WASL, WNT16, AHCYL2, ARF5, ATP6V1F, CALU, 
CCDC136, CEP41, COPG2, CPA1, CPA4, CPA5, FAM71F1, FAM71F2, FLNC, FSCN3, GCC1, 
HIG2, IMPDH1, IRF5, KLHDC10, LRRC4, MEST, MGC127766, MKLN1, NRF1, OB, OPN1SW, 
PAX4, PODXL, PRRT4, RBM28, SMO, SND1, STRIP2, TMEM209, TNPO3, TSGA13, TSPAN33, 
UBE2H, ZC3HC1, ZNF800 
Hap-
map55237-rs29010308 5 ALX1, LRRIQ1, MGAT4C, NTS, RASSF9, SLC6A15, TSPAN19 
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rs41257360 5 
APOLD1, BCL2L14, BOTA-T2R10B, CDKN1B, CREBL2, CSDA, DDX47, DUSP16, EMP1, ETV6, 
GPR19, GPRC5A, GPRC5D, GRIN2B, GSG1, HEBP1, KIAA1467, KLRA1, KLRC1, KLRJ1, 
LOH12CR1, LRP6, MAGOHB, MANSC1, NKG2A, STYK1, T2R10C, T2R12, T2R65A, TAS2R10, 
TAS2R42, TAS2R46 
rs29017739/rs29001782/ 
rs41588957/Hapmap6022
4-rs29001782/rs1103209
75/rs110289032/rs416109
91/rs109427807/rs811503
88/rs110707460/rs110527
224/rs43338539/rs108988
814/rs42766480/rs427664
80/ 
rs41617692/rs41655332/ 
rs41655339/rs41617947/r
s41653149   
6 
LPHN3, ADAMTS3, AFM, AFP, ALB, AMBN, AMTN, ANKRD17, ANTXR2, ANXA3, ART3, BMP2K, 
BTC, CABS1, CCDC158, CCNG2, CCNI, CDKL2, CENPC1, CNOT6L, COX18, CSN1S1, CSN1S2, 
CSN2, CSN3, CXCL10, CXCL11, CXCL13, CXCL2, CXCL3, CXCL6, CXCL9, DCK, 
DKFZP564O0823, DYNLL1, ENAM, EPGN, EPHA5, EREG, FAM47E-STBD1, FRAS1, G3BP2, GC, 
GK2, GNRHR, GRO1, GRSF1, HSTN, IGJ, CXCL8, MGC152010, MOB1B, MRPL1, MTHFD2L, 
NAA11, NAAA, NPFFR2, NUP54, ODAM, PAQR3, PF4, PPBP, PPEF2, RASSF6, RCHY1, RPL23A, 
RUFY3, SCARB2, SDAD1, SHROOM3, SLC25A16, SLC4A4, SOWAHB, STAP1, STATH, SULT1B1, 
SULT1E1, TECRL, THAP6, TMPRSS11A, TMPRSS11D, TMPRSS11F, UBA6, UGT2A3, USO1, 
UTP3, YTHDC1 
rs41664497/ 
rs110927426 
6 
ADH4, ADH5, ADH6, ADH7, BANK1, BDH2, C4orf17, CENPE, CISD2, DAPP1, DDIT4L, 
DNAJB14, EIF4E, EMCN, H2AFZ, LAMTOR3, MANBA, METAP1, MGC157237, MTTP, NFKB1, 
NHEDC1, PPP3CA, RAP1GDS1, SLC39A8, SLC9B2, TRMT10A, TSPAN5 
rs29013992/rs109746386 6 LPHN3 
rs110066189 7 
ACER1, ACP5, ACTL9, ADAMTS10, ALKBH7, ANGPTL4, ANGPTL6, AP1M2, ATG4D, C19orf38, 
C19orf45, C19orf59, C19orf80, C3, C7H19orf52, C7H19orf66, CAMSAP3, CARM1, CCDC151, 
CCDC159, CCL25, CD209, CD320, CD70, CDC37, CDKN2D, CERS4, CLEC4G, CLPP, CNN1, 
COL5A3, CTXN1, DENND1C, DNM2, DNMT1, DOCK6, ECSIT, EIF3G, ELAVL1, ELAVL3, ELOF1, 
EMR1, EPOR, EVI5L, FBN3, FBXL12, FCER2, FDX1L, GPR108, GTF2F1, ICAM1, ICAM3, ICAM4, 
ICAM5, ILF3, IR-A, KANK2, KANK3, KEAP1, KHSRP, KRI1, LDLR, LRRC8E, MAP2K7, 02-Mar, 
MCOLN1, MLLT1, MRPL4, MYO1F, NDUFA7, OLFM2, OR2Z1, P2RY11, PCP2, PDE4A, PEX11G, 
PIN1, PNPLA6, PPAN-P2RY11, PRAM1, PRKCSH, PSPN, QTRT1, RAB11B, RAB3D, RAVER1, 
RDH8, RETN, RGL3, RPS28, S1PR2, S1PR5, SH2D3A, SLC25A23, SLC25A41, SLC44A2, SNAPC2, 
SPC24, STXBP2, SWSAP1, TIMM44, TMED1, TMEM205, TNFSF14, TNFSF9, TRAPPC5, TRIP10, 
TSPAN16, TUBB4A, TYK2, VAV1, XAB2, YIPF2, ZGLP1, ZNF266, ZNF358, ZNF414, ZNF558, 
ZNF653 
rs110213141 7 
AKAP8, AKAP8L, AP1M1, BRD4, C19orf44, CALR3, CASP14, CCDC105, CHERP, CIB3, CYP4F2, 
CYP4F22, CYP4F3, EPHX3, EPS15L1, FAM32A, ILVBL, NOTCH3, OR10H1, OR7C2, PGLYRP2, 
RAB8A, RASAL3, SLC1A6, SYDE1, TPM4, WIZ 
rs41657989/ Hap-
map50931-BTA-31235/ 
rs41596179  
7 
7SK, ACSL6, ADAMTS19, ALDH7A1, C5orf63, C7H5orf48, CDC42SE2, CHSY3, CSF2, CTXN3, 
FBN2, FNIP1, GRAMD3, HINT1, IL3, ISOC1, KIAA1024L, LMNB1, LYRM7, MEGF10, P4HA2, 
PDLIM4, PHAX, PRRC1,, SLC12A2, SLC27A6, ZNF608 
rs41665468 9 ADGB, GRM1, KATNA1, LATS1, LRP11, MGC133692, NUP43, PCMT1, PPIL4, PPP1R14C, RAB32, RAET1G, RYK, SAMD5, SASH1, STXBP5, TAB2, ULBP3, ZC3H12D 
rs41654612 10 
ADCK1, AHSA1, ALKBH1, ANGEL1, C14orf166B, DIO2, GSTZ1, IRF2BPL, ISM2, KIAA1737, NGB, 
NOXRED1, NRXN3, POMT2, SAMD15, SLIRP, SNW1, SPTLC2, TMED8, TMEM63C, VASH1, 
VIPAS39, ZDHHC22 
rs43619106 10 AQR, C10H15ORF41, DPH6, FAM98B, MEIS2, RASGRP1, SPRED1, TMCO5A, ZNF770 
rs43673004 11 
ABCG5, ABCG8, ATP6V1E2, CAMKMT, CRIPT, DYNC2LI1, EPAS1, LRPPRC, MCFD2, PIGF, 
PLEKHH2, PPM1B, PREPL, PRKCE, RHOQ, SIX2, SIX3, SLC3A1, SOCS5, SRBD1, THADA, 
TMEM247, TTC7A, ZFP36L2 
rs109934030/ 
rs41634110/ 
rs109441194 
13 
ARFGEF2, ATP9A, B4GALT5, BCAS4, CSE1L, DDX27, DPM1, FAM65C, KCNB1, KCNG1, 
MOCS3, NCOA3, NFATC2, PARD6B, PREX1, PTGIS, PTPN1, RNF114, SALL4, SLC9A8, SNAI1, 
SPATA2, STAU1, SULF2, TMEM189, TSHZ2, UBE2V1, ZFP64, ZNF217, ZNFX1 
rs111004585 13 BTBD3, C20ORF13, C20ORF82, JAG1, MKKS, SLX4IP, SNAP25, SPTLC3, SRY 
rs41628293 13 
ARMC4, BAMBI, BANF2, BFSP1, C13H20ORF12, C20orf26, CRNKL1, CSRP2BP, DSTN, DTD1, 
MGME1, MKX, MPP7, NAA20, OVOL2, PCSK2, POLR3F, RAB18, RBBP9, RIN2, RPL5, RRBP1, 
SCP2D1, SEC23B, SLC24A3, SLC6A9, SNX5, WAC, ZNF133 
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rs41694067/ 
rs110942493/rs41601522
/rs29022774/rs29022775
/ rs41576572 
13 
ACSS2,, ACTL10, AHCY, ANKRD60, APCDD1L, ASIP, ASXL1, ATP5E, AURKA, BASE, BCL2L1, 
BMP7, BORIS, BPIFA1, BPIFA2B, BPIFB1, BPIFB2, BPIFB3, BPIFB4, BPIFB6, BSP30C, BSP30D, 
C13H20ORF108, C13H20ORF71, C13H20ORF85, C20orf112, C20orf144, C20ORF18, C20orf96, 
CASS4, CBFA2T2, CCM2L, CDH26, CDH4, CDK5RAP1, CEP250, CHMP4B, COMMD7, COX4I2, 
CSNK2A1, CSTF1, CTSZ, DEFB119, DEFB122, DEFB122A, DEFB123, DEFB124, DEFB129, 
DNMT3B, DUSP15, DYNLRB1, E2F1, EDEM2, EDN3, EIF2S2, EIF6, FAM110A, FAM209B, 
FAM217B, FAM83C, FKBP1A, FOXS1, GCNT7, GDF5, GGT7, GNAS, GSS, HCK, HM13, ID1, 
ITCH,KIF3B, MAP1LC3A, MAPRE1, MMP24, MYH7B, MYLK2, NCOA6, NECAB3, NELFCD, 
NPEPL1, NRSN2, NSFL1C, PCK1, PDRG1, PHACTR3, PIGU, PLAGL2, PMEPA1, POFUT1, 
PPP1R3D, PROCR, PSMF1, PXMP4, RAB22A, RAD21L1, RAE1, RALY, RBM38, REM1, RSPO4, 
RTFDC1, SDCBP2, SIRPB2, SIRPD, SLC52A3, SLMO2, SNPH, SNTA1, SPAG4L, SPO11, SRXN1, 
SS18L1, STX16, SYCP2, TAF4, TBC1D20, TCF15, TFAP2C, TM9SF4, TMEM74B, TP53INP2, TPX2, 
TRIB3, TRPC4AP, TTLL9, TUBB1, UQCC, VAPB,, XKR7, ZBP1, ZCCHC3, ZNF341, ZNF831 
rs109146371/ 
rs109421300/ 
rs109350371 
 
14 
ADCK5, ARC, ARHGAP39, BAI1, C14H8orf82, C8orf33, CCDC166, COMMD5, CPSF1, CYC1, 
CYHR1, DENND3, DGAT1, EEF1D, EXOSC4, FAM83H, FBXL6, FOXH1, GML, GPAA1, GPR172B, 
GPR20, GPT,GRINA ,GSDMD ,HSF1 ,KIAA1875 ,KIFC2 , LRRC14, LRRC24, LY6D, LY6E, LY6H, 
LY6K, LYNX1, LYPD2, MAF1, MAFA, MAPK15, MFSD3, MROH1, MROH6, NAPRT1, NRBP2, 
OPLAH, PARP10, PLEC, PPP1R16A, PSCA, PTK2, PTP4A3, PUF60, PYCRL, RECQL4, RHPN1, 
RPL8, SCRIB, SCRT1, SHARPIN, SLC39A4, SLC45A4, SLURP1, SPATC1, THEM6, TIGD5, 
TMEM249, TMEM60, TONSL, TSNARE1,TSTA3 , VPS28, ZC3H3, ZNF16, ZNF34, ZNF623, ZNF7 
rs29012803 14 ANXA13, ATAD2, DERL1, FAM83A, FAM91A1, FBXO32, FER1L6, H3F3C, HAS2, KLHL38, PRKDC, SPIDR, TBC1D31, UBE2V2, WDYHV1, ZHX1, ZHX2 
rs41629827/ 
rs41630587/ rs41620570  14 
AARD, COLEC10, CSMD3, EIF3H, EXT1, FABP12, FABP4, FABP5, FABP9, HEY1, IL7, MAL2, 
MED30, MRPS28, NOV, PAG1, PKIA, PMP2, RAD21, SAMD12, STMN2, TNFRSF11B, TPD52, 
TRPS1, UTP23, ZBTB10,ZC2HC1A ,ZNF704  
rs110034639 16 ESRRG, GPATCH2, LYPLAL1, RRP15, TGFB2, USH2A 
rs41579632 16 
ATP1B1, BLZF1, C1orf112, CCDC181, CEP170, CHML, DPT, EXO1, F5, FH, KIFAP3, KMO, 
MAP1LC3C, METTL11B, METTL18, NME7, PLD5, RGS7, SCYL3, SELE, SELL, SELP, SLC19A2, 
WDR64, XCL1 
rs41616806 17 ANKRD50, BBS12, CETN4, FAT4, FGF2, NUDT6, SPATA5, SPRY1 
rs110754697 18 
ACSF3, ANKRD11, APRT, BANP, C16orf95, C18H16orf87, CA5A, CBFA2T3, CDH15, CDK10, 
CDT1, CHMP1A, CPNE7, CTU2, CYBA, DBNDD1, DEF8, DNAJA2, DPEP1, FANCA, FBXO31, 
FOXC2, FOXF1, FOXL1, GALNS, GAS8, GPT2, IL17C, IRF8, ITFG1, JPH3, KLHDC4, LAT, 
MAP1LC3B, MC1-R, MGC157263, MTHFSD, MVD, MYLK3, NETO2, ORC6, PABPN1L, PIEZO1, 
RNF166, RPL13, SHCBP1, SNAI3, SPATA2L, SPG7, SPIRE2, TCF25, TRAPPC2L, TUBB3, VPS35, 
VPS9D1, ZC3H18, ZCCHC14, ZFPM1, ZNF276, ZNF469 
rs29014958 18 
AARS, ADAT1, BCAR1, BCNT, CFDP1, CNTNAP4, COG4, CTRB1, DDX19A, DDX19B, EEF1A1, 
FA2H, FUK, GABARAPL2, GLG1, IL34, KARS, LDHD, MLKL, MRCL, MTSS1L, P97BCNT2, PDPR, 
RFWD3, SF3B3, SIAT4B, TERF2IP, TMEM170A, TMEM231, UQCRFS1, VAC14, VSTM2B, WDR59, 
ZFP1, ZNRF1 
rs29020544 18 
ANKRD27, CEBPG, CEP89, CHST8, DPY19L3, FAAP24, GPATCH1, GPI, KCTD15, KIAA0355, 
LRP3, LSM14A, NUDT19, PDCD2L, PDCD5, PEPD, RGS9BP, RHPN2, SLC7A10, SLC7A9, 
TDRD12, TSHZ3, UBA2, WDR88, WTIP, ZNF507 
rs41578926 18 MON1B, SYCE1L 
rs41257403/ 
rs41636878 
19 
AATK, ACTG1, ALYREF, ANAPC11, ARHGDIA, ARL16, ASPSCR1, AZI1, BAIAP2, BPTF, 
C17orf62, C17orf70, C1QTNF1, CANT1, CARD14, CBX2, CBX4, CBX8, CCDC137, CCDC40, 
CCDC47, CCDC57, CD7, CD79B, CEP95, CHMP6, CSNK1D, CYTH1, DCXR, DDX42, DDX5, 
DNAH17, DUS1L, EIF4A3, ENDOV, ENGASE, ENPP7, ENTHD2, ERN1, FAM195B, FASN, FN3K, 
FN3KRP, FOXK2, FSCN2, FTSJ3, GAA, GCGR, GH1, GPS1, HEXDC, HGS, ICAM2, KPNA2, 
LGALS3BP, LRRC45, MAFG, METRNL, MILR1, MRPL12, MYADML2, NARF, NOL11, NPB, 
NPLOC4, NPTX1, OGFOD3, OXLD1, P4HB, PCYT2, PDE6G, PGS1, POLG2, PPP1R27, 
PSMC5,PSMD12 ,PYCR1 ,RAB40B , RAC3, RBFOX3, RFNG, RNF213, RPTOR, SCN4A, SECTM1, 
SGSH, SIRT7, SLC16A3, SLC26A11, SLC38A10, SMARCD2, SMURF2,STRA13 , STRADA, 
TBC1D16, TBCD, TEX2, TIMP2, TSPAN10, USMG5, USP36, UTS2R, WDR45L,ZNF750  
rs109838275 20 ADAMTS16, ADCY2, IRX1, KIAA0947, MED10, NSUN2, PAPD7, SRD5A1,  
rs41577870  20 CDH10, CDH9 
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rs41628334/ 
rs41639270/rs41639268/
rs41940571/rs29021255/
rs41942930/ rs41578305  
20 
ADAMTS12, AGXT2, AMACR, BRIX1, C1QTNF3, C20H5ORF22, C20H5orf34, C5orf28, C5orf42, 
C5orf51, C6, C7, C9, CAPSL, CARD6, CCDC152, CCL28, CDH6, DAB2, DNAJC21, DROSHA, 
EGFLAM, EMB, FBXO4, FYB, GDNF, GHR, GOLPH3, HCN1, HMGCS1, IL7R, LIFR, LMBRD2, 
MROH2B, MRPS30, MTMR12, NADK2, NIM1K, NIPBL, NNT, NPR3, NUP155, OSMR, OXCT1, 
PAIP1, PARP8, PLCXD3, PRKAA1, PRLR,PTGER4, RAD1, RAI14, RANBP3L, RICTOR, RPL37, 
RXFP3, SKP2, SLC1A3, SLC45A2, SPEF2, SUB1, TARS, TTC23L, TTC33, UGT3A1, WDR70, ZFR, 
ZNF131 
rs41654340 
 
23 
ABT1, ALDH5A1, BTN1A1, C23H6ORF62, DCDC2, FAM65B, GMNN, GPLD1, H2B, HFE, 
HIST1H1A, HIST1H1C, HIST1H1D, HIST1H1E, HIST1H2AC, HIST1H2AD, HIST1H2AG, 
HIST1H2AJ, HIST1H2BA, HIST1H2BB, HIST1H2BI, HIST1H2BJ, HIST1H2BK, HIST1H3A, 
HIST1H3B, HIST1H3E,HIST1H3H, HIST2H4B, HIST4H4, HMGN4, KIAA0319, LRRC16A, 
MGC157324, MRS2, NKAPL, OR12D3, OR14J1, OR2B6, PGBD1, POM121L2, PRSS16, SCGN, 
SLC17A1, SLC17A2, SLC17A3, SLC17A4, TDP2, THEM2, TRIM27, TRIM38, ZNF165, ZNF184, 
ZNF192, ZNF311, ZNF323, ZNF391, ZSCAN12, ZSCAN16, ZSCAN9 
BFGL-NGS-119848 25 
ATF7IP2, BCAR4, CIITA, CLEC16A, CPPED1, DEXI, EMP2, ERCC4, GSPT1, LITAF, MKL2, 
NUBP1, PRM1, PRM2, PRM3, RMI2, RSL1D1, SHISA9, SNN, SNX29, SOCS1, TEKT5, TNP2, 
TVP23A, TXNDC11, ZC3H7A 
Hap-
map25382-BTC-000577 25 
ADCY9, ALG1, ANKS3, C16orf89, C25H16ORF71, CDIP1, CORO7, DNAJA3, FAM86A, GLIS2, 
GLYR1, HMOX2, MGC142811, MGRN1, NAGPA, NMRAL1, NUDT16L1, PAM16, PPL, RBFOX1, 
ROGDI, SEC14L5, 12-Sep, SRL, TFAP4, UBN1, VASN, ZNF500 
rs41606777 26 
ATRNL1, C10orf82, CACUL1, CCDC172, EIF3A, EMX2, ENO4, FAM204A, FAM45A, GFRA1, 
GRK5, HSPA12A, KCNK18, KIAA1598, PDZD8, PNLIP, PNLIPRP2, PNLIPRP3, PRDX3, PRLHR, 
RAB11FIP2, SFXN4, SLC18A2, VAX1 
rs41650611 26 
ALDH18A1, ANKRD2, AVPI1, BLNK, C10orf12, CCNJ, CRTAC1, CYP2C18, CYP2C19, CYP2C87, 
DNTT, ENTPD1, EXOSC1, FRAT1, FRAT2, GOLGA7B, HELLS, HOGA1, HPS1, LCOR, LOXL4, 
MARVELD1, MMS19, MORN4, NOC3L, OPALIN, PDLIM1, PGAM1, PI4K2A, PIK3AP1, PLCE1, 
PYROXD2, R3HCC1L, RRP12, SFRP5, SLIT1, SORBS1, TBC1D12, TCTN3, TLL2, TM9SF3, 
UBTD1, ZDHHC16, ZFYVE27 
rs41648482 28 
ACTN2, ARID4B, B3GALNT2, EDARADD, ERO1LB, GGPS1, GNG4, GPR137B, HEATR1, 
IRF2BP2, KCNK1, LGALS8, LYST, MTR, NID1, RBM34, RYR2, SLC35F3, TARBP1, TBCE, 
TOMM20 
rs29027496 29 
ADRBK1, AIP, ALDH3B1, ALDH3B2, ANKRD13D, AP5B1, ARL2, ATG2A, ATL3, B3GNT1, BAD, 
BANF1, BATF2, BRMS1, C11orf80, C11orf85, C29H11orf68, C29H11orf84, C29H11orf86, CABP2, 
CABP4, CAPN1, CARNS1, CATSPER1, CCDC85B, CCDC87, CCDC88B, CCS, CD248, 
CDC42BPG, CDC42EP2, CDCA5, CDK2AP2, CFL1, CHKA, CLCF1, CORO1B, CST6, CTSF, 
CTSW, DNAJC4, DOC2G, DPF2, DPP3, DRAP1, EFEMP2, EHBP1L1, EHD1, EIF1AD, ESRRA, 
FAU, FERMT3, FIBP, FKBP2, FLRT1, FOSL1, FRMD8, GAL3ST3, GPHA2, GPR137, GPR152, 
GSTP1, KAT5, KCNK4, KCNK7, KDM2A, KLC2, LGALS12, LRFN4, LTBP3, MACROD1, 
MAP3K11, MAP4K2, MARK2, MEN1, MGC140823, MRPL11, MRPL49, MUS81, NAALADL1, 
NAT11, NDUFS8, NDUFV1, NPAS4, NRXN2, NUDT22, NUDT8, OTUB1, OVOL1, PACS1, PC, 
PCNXL3, PELI3, PITPNM1, PLA2G16, PLCB3,POLA2 ,POLD4 ,PPP2R5B, PRDX5, PTPRCAP, 
PYGM, RAB1B, RAD9A, RASGRP2, RBM14, RBM4, RBM4B, RCE1, RCOR2, RELA, RHOD, RIN1, 
RNASEH2C, RPS6KA4, RPS6KB2, RTN3, SAC3D1, SART1, SCYL1, SF1, SF3B2, SIPA1, SLC22A11, 
SLC22A12, SLC25A45, SLC29A2, SNX15, SNX32, SPDYC, SPTBN2, SSH3, SSSCA1, STIP1, 
SUV420H1, SYT12, SYVN1, TBC1D10C, TBX10, TCIRG1, TIGD3, TM7SF2, TMEM134, 
TMEM151A, TRMT112, TRPT1, TSGA10IP, UNC93B1, VEGFB, VPS51, YIF1A, ZDHHC24, ZFPL1, 
ZNHIT2 
rs41608052 29 ARHGAP32, BARX2, ETS1, FLI1, IGSF9B, JAM3, KCNJ1, KCNJ5, NTM, OPCML, SPATA19 
Hap-
map42724-BTA-91683 X 
ACTRT1, AIFM1, APLN, BCORL1, CCDC169, CXHXorf64, ELF4, GPR119, IRF2BP1, OCRL, 
RAB33A, RBMX2, SASH3, SLC25A14, SMARCA1, UTP14A, XPNPEP2, ZDHHC9, ZNF280C 
rs109224945/ 
BTA-94079-no-rs  X CASK, DDX3X, DUSP21, FUNDC1, GPR34, GPR82, MAOA, MAOB, MED14, , NDP, NYX, USP9Y 
rs41629005 X AFF2, CXORF23, FMR1, FMR1NB, IDS, MAP7D2, SLITRK2 
#Gene selection is based on UMD 3.1 genome assembly. 
+Underscore denotes SNPs which appear in different GWAS files. 
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Table S5. IPA function analysis on the 1635# candidate genes selected from genome-wide association study with SCC in 
dairy cows.  
Name Molecules 
Diseases and Disorders  
Cancer 1130 
Gastrointestinal Disease 526 
Inflammatory Response 73 
Hepatic System Disease 17 
Infectious Disease 24 
Molecular and Cellular Functions  
Cell-To-Cell Signalling and Interaction 76 
Cellular Movement 76 
Energy Production 8 
Small Molecule Biochemistry 42 
Cell Morphology 254 
Physiological System Development and Function  
Haematological System Development and Function 181 
Immune Cell Trafficking 53 
Tissue Development 150 
Auditory and Vestibular System Development and Function 10 
Organ Morphology 105 
#1568 Genes with known IPA-eligible human and rodent orthologs were considered. 
 
Table S6. Top 10 signalling pathways from IPA among the 1635# candidate genes selected from genome-wide association 
study with SCC in dairy cows.  
Canonical pathways* Molecules Ratio 
Agranulocyte Adhesion and Diapedesis 28 1.47E−01 
Granulocyte Adhesion and Diapedesis 25 1.4E−01 
NAD Phosphorylation and Dephosphorylation 6 3E−01 
Proline Biosynthesis I 5 3.57E−01 
Role of JAK2 in Hormone−like Cytokine Signalling 8 2.29E−01 
IL−17A Signalling in Gastric Cells 6 2.4E−01 
Protein Kinase A Signalling 41 1.04E−01 
Remodelling of Epithelial Adherens Junctions 11 1.62E−01 
Serotonin Degradation 12 1.54E−01 
Ethanol Degradation II 8 1.86E−01 
*All pathways with P < 0.01 
#1568 genes with known IPA-eligible human and rodent orthologs were considered. 
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Figure S1. IPA Network 1 based on candidate genes for mastitis involved in Cancer, Organismal Survival, Cellular Move-
ment. Red denotes up-regulation and green down-regulation of the gene. The shapes of nodes indicate different types of gene 
product as shown in the insert. Note that although the pathway is classified in IPA under “cancer” the same genes are also 
involved in proliferation and migration of normal cells and are thus relevant to the cellular changes to infection in the bovine 
mammary gland. 
